Abstract
Since the isolation and characterization of cAMP in early 1957, several enzymatic and chemical synthetic procedures have been developed to provide cAMP and various cyclic nucleotide analogs. The synthesis of cAMP and 2′-deoxy-cAMP by bacterial fermentation is of current commercial interest as a low cost source of nucleoside 3′,5′-cyclic phosphates. In this chapter, the improvements made over the years on the original synthesis of cAMP (via DCC mediated cyclization of AMP) by employing different coupling reagents, transesterification of “active” phosphates of AMP and isolation techniques are reviewed. By far the largest number of cyclic nuceotide derivatives have been prepared by the chemical transformation of parent cAMP and cGMP itself. A substantial number of cAMP derivates have been synthesized in which there are substituent modifications of the purine base, and structural modifications of the carbohydrate moiety and the cyclic phosphate moiety. Representative examples of cyclic nucleotide analogs related to cAMP, such as 1-deazapurine, 3-deazapurine, 7-deazapurine, 2-azapurine, 8-azapurine, formycin, and l,N6-ethenoadenosine cyclic phosphates, are treated in some detail. Description of some of the more important methods currently being used for the preparation of cyclic nucleotides related to cGMP and pyrimidine cyclic nucleotides are presented. Detailed information about the hydrolytic and spectral properties of cyclic nucleotides are also included. Due to the recent availability of an enormous number of synthetic cyclic nucleotide analogs, considerable success has been achieved in obtaining potent phosphodiesterase (PDE) inhibitors with greater tissue specificity. We now have cyclic nucleotides which are more resistant toward cellular PDE than the parent cAMP and, consequently, survive intracellularly long enough to provide an increased physiological response. An effort has been made, in the present chapter, to show that future cyclic nucleotide chemistry has the potential to provide highly potent cyclic nucleotide derivatives, which may have a significant effect on uncontrolled cellular proliferation, the immune response, asthma, the central nervous system, gastrointestinal function and other physiological responses characteristic of the natural cyclic nucleotides.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abou-Sabe M (1976) Cyclic nucleotides and the regulation of cell growth. Dowden, Hutchinson and Ross, Inc. Stroudsburg PA
Agence Nationale de Valorisation de la Recherche (1972) Cyclic (iso) adenosine-3′,5′-mono-phosphoric acid. French Patent 2,112,084
Akerfeldt S (1962) Further studies on S-substituted phosphorothioic acids. II. Synthesis and certain properties of some potential antiradiation drugs. Acta Chim Scand 16:1897–1907
Alberty RA (1969) Standard Gibbs free energy, enthalpy, and entropy changes as a function of pH and pMg for several reactions involving adenosine phosphates. J Biol Chem 244:3290–3302
Albrecht HP, Jones GH, Moffat JG (1970) 3′-Deoxy-3′-(dihydroxyphosphinylmethyl)nucleosides. Isosteric phosphonate analogs of nucleoside 3′-phosphates. J Am Chem Soc 92:5511–5513
Allen LB, Boswell KH, Khwaja TA, Meyer RB Jr, Sidwell RW, Witkowski JT, Christensen LF, Robins RK (1978) Synthesis and antiviral activity of some phosphates of the broad-spectrum antiviral nucleoside, 1-β-D-ribofuranosyl-1,2,3-triazole-3-carboxamide (Ribavirin). J Med Chem 21:742–746
Allen LB, Eagle NC, Huffman JH, Shuman DA, Meyer RB Jr, Sidwell RW (1974) Enhancement of interferon antiviral action in L-cells by cyclic nucleotides. Proc Soc Exp Biol Med 146:580–584
Amer MS (1975) Cyclic nucleotides in disease; on the biochemical etiology of hypertension. Life Sci 17:1021–1038
Amer MS, McKinney GR (1973) Possibilities for drug development based on the cyclic AMP system. Life Sci 13:753–767
Amer MS, McKinney GR (1974) Cyclic nucleotides and drug discovery. Annu Rept Med Chem 9:203–212
Amer MS, McKinney GR (1975) Cyclic nucleotides as mediators of drug action. Annu Rept Med Chem 10:192–201
Anderson WB, Johnson GS, Pastan IH (1973a) Transformation of chick-embryo fibroblasts by wild-type and temperature-sensitive Rous Sarcoma virus alters adenylate cyclase activity. Proc Natl Acad Sci USA 70:1055–1059
Anderson WB, Lovelace E, Pastan I (1973 b) Adenylate cyclase activity is decreased in chick embryo fibroblasts transformed by wild type and temperature sensitive Schmidt-ruppin rous sarcoma virus. Biochem Biophys Res Commun 52:1293–1299
Anderson WB, Perlman RL, Pastan I (1972) Effect of adenosine 3′,5′-monophosphate analogs on the activity of the cyclic adenosine 3′,5′-monophosphate receptor in Escherichia coli. J Biol Chem 247:2717–2722
Anisuzzaman AKM, Lake WC, Whistler RL (1973) 4′-Thioadenosine 3′,5′-cyclic phosphate and derivatives. Chemical synthesis and hydrolysis by phosphodiesterase. Biochemistry 12:2041–2045
Ashman DF, Lipton R, Melicow MM, Price TD (1963) Isolation of adenosine 3′,5′-mono-phosphate and guanosine 3′,5′-monophosphate from rat urine. Biochem Biophys Res Commun 11:330–334
Baddiley J, Buchanan JG, Szabo L (1954) Sugar phosphates. Part I. Derivatives of glucose 4:6-(hydrogen phosphate). J Chem Soc 3826–3839
Baglioni C (1979) Interferon-induced enzymatic activities and their role in the antiviral state. Cell 17:255–264
Baglioni C, Minks MA, Maroney PA (1978) Interferon action may be mediated by activation of a nuclease by pppA2′A2′A. Nature 273:684–687
Bahr JT, Cathou RE, Hammes GG (1965) A thermodynamic study of the hydrolysis of cytidine 2′,3′-cyclic phosphate. J Biol Chem 240:3372–3378
Bald RW, Holý A (1971) Nucleic acid components and their analogues. CXLII. Preparation of 3-(β-D-ribofuranosyl)uracil 2′,3′-cyclic phosphate and related compounds and their behaviour towards pancreatic ribonuclease and ribonuclease T2. Coll Czech Chem Commun 36:3657–3669
Baraniak J, Lesiak K, Stec WJ (1979) Assignment of absolute configuration at phosphorus in diastereoisomeric adenosine 3′,5′-cyclic phosphorothioates (cAMPS). Pol J Chem 53:1387–1391
Barker GR, Montague MD, Moss RJ, Parsons MA (1957) Biosynthesis of polynucleotides. Part I. The mode of action of ribonuclease. J Chem Soc 3786–3793
Barker GR, Foll GE (1957) Biosynthesis of polynucleotides. Part II. The synthesis and properties of phosphoryl derivatives of adenine glucoside. J Chem Soc 3794–3798
Barry CD, Martin DR, Williams RJP, Xavier AV (1974) Quantitative determination of the conformation of cyclic 3′,5′-adenosine monophosphate in solution using lanthanide ions as nuclear magnetic resonance probes. J Mol Biol 84:491–502
Baschang G, Kvita V (1973) New derivatives of thymidine 3′,5′-cyclophosphate. Angew Chem (Engl) 12:71–72
Beaman AG, Robins RK (1962) Potential purine antagonists. XXXIII. Synthesis of chloropurines. J Appl Chem 12:432–437
Berger NA, Eichhorn GL (1971) Interaction of metal ions with polynucleotides and related compounds. XIV. Nuclear magnetic resonance studies of the binding of copper (II) to adenine nucleotides. Biochemistry 10:1847–1857
Bergmeyer HU, Michal G, Nelboeck-Hochstetter M, Stork H, Weimann G, (Boehringer Mannheim GmbH) (1971) Antilipolytic cyclophosphate derivatives of 5-amino-1-β-D-ribosylimidazole-4-carboxamides. German Patent 2,026,040
Bergmeyer HU, Nelboeck-Hochstetter M, Michal G, Muehlegger K, Weimann G, Roesch E (1972) Substituted purine ribonucleoside 3′-cyclic phosphates. Ger. Offen. 2,125,077
Besancon F, Ankel H (1974) Binding of interferon to gangliosides. Nature 252:478–480
Biron KK, Raska K Jr (1973) Effects of dibutyryl-cAMP on adenovirus replication in different cell lines. Virology 56:383–385
Blackburn BJ, Lapper RD, Smith ICP (1973) A proton magnetic resonance study of the conformations of 3′,5′-cyclic nucleotides. J Am Chem Soc 95:2873–2878
Blackburn GM, Cohen JS, Todd Lord (1964) Cyclic phosphate and phosphate triesters — A P31 N.M.R. study. Tetrahedron Lett 2873–2879
Blalock JE, Stanton JD (1980) Common pathways of interferon and hormonal action. Nature 283:406–408
Blecher M, Ro’Ane JT, Flynn PD (1970) Metabolism of dibutyryl cyclic adenosine 3′,5′-monophosphate during its regulation of lipolysis and glucose oxidation in isolated rat epididymal adipocytes. J Biol Chem 245:1867–1870
Bloch A, private communication
Bloch A (1974) Cytidine 3′,5′-monophosphate (cyclic CMP). I. Isolation from extracts of leukemia L-1210 cells. Biochem Biophys Res Commun 58:652–659
Bloch A (1975 a) Isolation of cytidine 3′,5′-monophosphate from mammalian tissues and body fluids and its effects on leukemia L-1210 cell growth in culture. Adv Cyclic Nu-cleotide Res 5:331–338
Bloch A (1975 b) Uridine 3′,5′-monophosphate (cyclic UMP). I. Isolation from rat liver extracts. Biochem Biophys Res Commun 64:210–218
Bloch A, Dutschman G, Maue R (1974) Cytidine 3′,5′-monophosphate (cyclic CMP). IL Initiation of leukemia L-1210 cell growth in vivo. Biochem Biophys Res Commun 59:955–959
Bloch A, Hromchak R, Henderson ES (1975) Isolation of cytidine 3′,5′-monophosphate (cyclic CMP) from the urine of leukemic patients. Proc Am Assoc Cancer Res 16:191
Bobek M, Whistler RL, Bloch A (1970) Preparation and activity of the 4′-thio derivatives of some 6-substituted purine nucleosides. J Med Chem 13:411–413
Bobruskin ID, Gulyaev NN, Kirpichnikov MP, Severin ES, Tunitskaya VA, Florent’ev VL (1979) Nuclear magnetic resonance study of conformation of nucleotides, oligonucleotides, and their analogs in solution. I. Conformation of adenosine-3′,5′-cyclophosphate and its analogs in aqueous solutions. Mol Biol (Mosk) 13:87–95
Boehringer Mannheim GmbH (1970 a) Cyclofosfaten en werkwijze voor hun bereiding. Nederland patent 6,913,671
Boehringer Mannheim GmbH (1970 b) Werkwijze voor het bereiden van de op 8-planta gemodificocorde purineribofuranoside 3′,5′-cyclofosfaten. Nederland Patent 7,003,222
Boehringer Mannheim GmbH (1971) Purineribofuranoside 3′,5′-cyclophosphates. British Patent 1,257,546
Borden RK, Smith M (1966 a) Nucleotide synthesis. II. Nucleotide p-nitrophenyl and 2,4-dinitrophenyl esters. J Org Chem 31:3241–3246
Borden RK, Smith M (1966b) Nucleotide synthesis. III. Preparation of nucleoside-3′,5′-cyclic phosphates in strong base. J Org Chem 31:3247–3253
Boswell KH, Christensen LF, Shuman DA, Robins RK (1975) Synthesis of 6,8-disubstituted-9-β-D-ribofuranosyrpurine 3′,5′-cyclic phosphates. J Heterocycl Chem 12:1–9
Boswell KH, Miller JP, Shuman DA, Sidwell RW, Simon LN, Robins RK (1973) Synthesis and biological activity of certain carbamoyl and alkoxycarbonyl derivatives of adenosine 3′,5′-cyclic phosphate. J Med Chem 16:1075–1079
Boswell KH, Robins RK (1979) The synthesis of 2-amino-6,8-disubstituted purine-9-β-D-ribofuranosyl-3′,5′-cyclic monophosphates from guanosine-3′,5′-cyclic monophosphate (c-GMP). J Carbohydr Nucleosides Nucleotides 6:359–370
Boyd DB (1969) Mechanism of hydrolysis of cyclic phosphate esters. J Am Chem Soc 91:1200–1205
Bradbury E, Nagyvary J (1976) Preparation of 2′-thio-2′-deoxycytidine 2′,3′-phosphorothioate. Nucleic Acids Res 3:2437–2442
Brenner T, Gorin E (1978) Metabolic fate of exogenous 5′-AMP, cyclic AMP and cyclic GMP in rats. Biochem Med 20:160–166
Broadus AE (1977) Clinical cyclic nucleotide research. Adv Cyclic Nucleotide Res 8:509–548
Broer Y, Fouchereau M, Rosselin G (1972) Dosages radio-immunologiques de l’AMPc et du GMPc. Preparation, purification et controle du 2′0 succinyl AMP-3′,5′-cyclique et du 2′0 succinyl-GMP-3′,5′-cyclique. CR. Acad Sci Paris 275D:619–622
Brooker G, Harper JF, Teraski WL, Moylan RD (1979) Radioimmunoassay of cyclic AMP and cyclic GMP. Adv Cyclic Nucleotide Res 10:1–33
Broom AD, Robins RK (1965) The direct preparation of 2′-O-methyladenosine from adenosine. J Am Chem Soc 87:1145–1146
Brown DM, Magrath DI, Todd AR (1952) Nucleosides. Part XII. The preparation of cyclic 2′,3′-phosphates of adenosine, cytidine, and uridine. J Chem Soc 2708–2714
Brown DM, Magrath DI, Sir Todd AR (1955) Nucleotides. Part XXXIV. The dydrolysis of dialkyl esters of uridine-3′ phosphate and its relevance to the question of phospho triester linkages in ribonucleic acids. J Chem Soc 4396–4401
Brown DM, Todd AR (1952) Nucleotides. Part X. Some observations on the structure and chemical behaviour of the nucleic acids. J Chem Soc 52–58
Brunswick DJ, Cooperman BS (1971) Photo-affinity labels for adenosine 3′,5′-cyclic monophosphate. Proc Natl Acad Sci USA 68:1801–1804
Bryan AM, Olafsson PG (1973) Calorimetric investigations of crystalline 3′,5′-cyclic nucleotides. Biopolymers 12:229–235
Butcher RW, Sutherland EW (1962) Adenosine 3′,5′-phosphate in biological materials. I. Purification and properties of cyclic 3′,5′-nucleotide phosphodiesterase and use of this enzyme to characterise adenosine 3′,5′-phosphate in human urine. J Biol Chem 237:1244–1250
Cailla H, Delaage M (1972) Succinyl derivatives of adenosine 3′,5′-cyclic monophosphate: Synthesis and purification. Anal Biochem 48:62–72
Calvet M-C, Gresser I (1979) Interferon enhances the excitability of cultured neurones. Nature 278:558–560
Carchman RA, Johnson GS, Pastan I, Scolnick EM (1974) Studies on the levels of cyclic AMP in cells transformed by wild-type and temperature-sensitive Kirsten sarcoma virus. Cell 1:59–64
Cech SY, Gross RA, Ignarro LJ (1976) Pharmacologist 18:223
Cech SY, Ignarro LJ (1977) Cytidine 3′,5′-monophosphate (cyclic CMP) formation in mammalian tissues. Science 198:1063–1065
Cech SY, Ignarro LJ (1978) Cytidine 3′,5′-monophosphate (cyclic CMP) formation by homogenates of mouse liver. Biochem Biophys Res Commun 80:119–125
Cehovic G, Bayer M, Giao N-B (1976) Synthesis of new cyclic nucleotides and their differential stimulatory effects on thyroid function in mice. J Med Chem 19:899–903
Cehovic G, Gabbal A, Marcus I, Posternak T (1971 a) Dérivés d’acide adénosine-3′,5′-phos-phorique cyclique et leur préparation. French patent 6,934,747
Cehovic G, Marcus I, Posternak T (1971 b) Iso-adenosine-3′,5′-monophosphorsäure und ihre Salze. German Patent 1,944,000
Cehovic G, Marcus I, Vengadabady S, Posternak T (1968) Sur la préparation de l’acide iso-adénosine-3′,5′-phosphorique (iso-AMP cyclique) et sur certaines de ses propriétés biologiques. CR Soc Phys Hist Nat 3:135–139
Chawla RK, Nixon DW, Shoji M, Rudman D (1979) Plasma and urine cyclic guanosine 3′,5′-monophosphate in disseminated cancer. Ann Int Med 91:862–864
Cheng YC, Bloch A (1978) Demonstration in leukemia L-1210 cells, of a phosphodiesterase acting on 3′,5′-cyclic CMP but not on 3′,5′-cyclic AMP or 3′,5′-cyclic GMP. J Biol Chem 253:2522–2524
Cherbuliez E, Probst H, Rabinowitz J (1959) Recherches sur 1a formation et la transformation des esters XVII. Sur la formation d’esters phosphoriques cycliques et sur la vitesse d’hydrolyse de ces esters et des esters dialcoylphosphoriques. Helv Chim Acta 42:1377–1384
Chládek S, Nagyvary J (1972) Nucleophilic reactions of some nucleoside phosphorothioates. J Am Chem Soc 94:2079–2085
Cho-Chung S (1974) In vivo inhibition of tumor growth by cyclic adenosine 3′,5′-mono-phosphate derivatives. Cancer Res 34:3492–3496
Christensen LF, Meyer RB Jr, Miller JP, Simon LN, Robins RK (1975) Synthesis and en-zymic activity of 8-acyl and 8-alkyl derivatives of guanosine 3′,5′-cyclic phosphate. Biochemistry 14:1490–1496
Christensen LF, Robins RK (1976) 8-Substituted cyclic nucleotides by free radical alkylation and acylation. US Patent 3,968,101
Chu SH, Shiue CY, Chu MY (1974) Synthesis and biological activity of some 8-substituted seleno cyclic nucleotides and related compounds. J Med Chem 17:406–409
Chu SH, Shiue CY, Chu MY (1975) Synthesis and biological activity of some 8-substituted selenoguanosine cyclic 3′,5′-phosphates and related compounds. J Med Chem 18:559–564
Chwang AK, Sundaralingam M (1973) Molecular conformation of guanosine 3′,5′-cyclic monophosphate. Nature New Biol 244:136–137
Chwang AK, Sundaralingam M (1974) The crystal and molecular structure of guanosine 3′,5′-cyclic monophosphate (cyclic GMP) sodium tetrahydrate. Acta Cryst 30B:1233–1240
Clark VL, Bernlohr RW (1972) Guanyl cyclase of Bacillus licheniformis. Biochem Biophys Res Commun 46:1570–1575
Coffino P, Gray JW (1978) Regulation of S49 lymphoma cell growth by cyclic adenosine 3′,5′-monophosphate. Cancer Res 38:4285–4288
Collin RL (1966) The electronic structure of phosphate esters. J Am Chem Soc 88:3281–3287
Cook WH, Lipkin D, Markham R (1957) The formation of a cyclic dianhydrodiadenylic acid (I) by the alkaline degradation of adenosine-5′-triphosphoric acid (II). J Am Chem Soc 79:3607–3608
Cotton FA, Gillen RG, Gohil RN, Hazen EE Jr, Kirchner CR, Nagyvary J, Rouse JP, Stanislowski AG, Stevens JD, Tucker PW (1975) Tumor-inhibiting properties of the neutral P-O-ethyl ester of adenosine 3′,5′-monophosphate in correlation with its crystal and molecular structure. Proc Natl Acad Sci USA 72:1335–1339
Coulter CL (1968) Cyclic uridine-3′,5′-phosphate: Molecular Structure. Science 159:888–889
Coulter CL (1969) The crystal and molecular structure of the triethylammonium salt of cyclic uridine-3′,5′-phosphate. Acta Cryst 25B:2055–2065
Coulter CL (1970) The crystal and molecular structure of the triethylammonium salt of the cyclic uridine-3′,5′-phosphate. Corrigendum. Acta Cryst 26B:441
Coulter CL (1973) Structural chemistry of cyclic nucleotides. IL Crystal and molecular structure of sodium β-cytidine 2′,3′-cyclic phosphate. J Am Chem Soc 95:570–575
Coulter CL, Greaves ML (1970) Cyclic cytidine 2′,3′-phosphate: Molecular structure. Science 169:1097–1098
Cox JR Jr, Wall RE, Westheimer FH (1959) Thermochemical demonstration of strain in a cyclic phosphate. Chem Ind (Lond) 929
Davoren PR, Sutherland EW, Maxwell AM (1963) The cellular location of adenyl cyclase in the pigeon erythrocyte. J Biol Chem 238:3016–3023
Dekker CA, Khorana HG (1954) Carbodiimides. VI. The reaction of dicyclohexylcar-bodiimide with yeast adenylic acid. A new method for the preparation of monoesters of ribonucleoside 2′-and 3′-phosphates. J Am Chem Soc 76:3522–3527
DeRubertis FR, Craven P (1977) Increased guanylate cyclase activity and guanosine 3′,5′-monophosphate content of ethionone-induced hepatomas. Cancer Res 37:15–21
DeRubertis FR, Chayoth R, Field JB (1976) The content and metabolism of cyclic adenosine 3′,5′-monophosphate and cyclic guanosine 3′,5′-monophosphate in adeno-carcinoma of the human colon. J Clin Invest 57:641–649
Dills WL Jr, Beavo JA, Bechtel PJ, Meyers KR, Sakai LJ, Krebs EG (1976) Binding of adenosine 3′,5′-monophosphate dependent protein kinase regulatory subunit to immobilized cyclic nucleotide derivatives. Biochemistry 15:3724–3731
Dills WL Jr, Goodwin CD, Lincoln TM, Beavo JA, Bechtel PJ, Corbin JD, Krebs EG (1979) Purification of cyclic nucleotide receptor proteins by cyclic nucleotide affinity chromatography. Adv Cyclic Nucleotide Res 10:199–217
Dimroth K, Witzel H, Hülsen W, Mirbach H (1959) Über die Hydrolyse von Ribonuclein-säuren in Gegenwart von Metallhydroxyden. Ann Chem 620:94–132
Drummond GI, Gilgan MW, Reiner EJ, Smith M (1964) Deoxyribonucleoside-3′,5′-cyclic phosphates. Synthesis and acid-catalyzed and enzymic hydrolysis. J Am Chem Soc 86:1626–1630
Drummond GI, Duncan L, Hertzman E (1966) Effect of epinephrine on Phosphorylase b kinase in perfused rat hearts. J Biol Chem 241:5899–5903
Drummond GI, Powell CA (1970) Analogues of adenosine 3′,5′-cyclic phosphate as activators of Phosphorylase b kinase and as substrates for cyclic 3′,5′-nucleotide phosphodiesterase. Mol Pharmacol 6:24–30
Drummond GI, Severson DL (1979) Cyclic nucleotides and cardiac function. Circ Res 44:145–153
Dunn DB, Hall RH (1970) Purines, pyrimidines, nucleosides and nucleotides: physical constants and spectral properties. In: Handbook of biochemistry, 2nd ed, Edit. Sober, Chemical Rubber Co., Cleveland, p G1–238
Eckstein F (1968) Uridine 2′,3′-O,O-cyclophosphorothioate as substrate for pancreatic ribonuclease. FEBS Lett 2:85–86
Eckstein F (1970) Nucleoside phosphorothioates. J Am Chem Soc 92:4718–4723
Eckstein F, Gindl H (1968) Uridin-2′,3′-O,O-cyclothiophosphat. Chem Ber 101:1670–1673
Eckstein F, Bär H-P (1969) Enzymatic hydrolysis of adenosine 3′,5′-cyclic phos-phorothioate. Biochim Biophys Acta 191:316–321
Eckstein F, Schulz HH, Rüterjans H, Haar W, Maurer W (1972) Stereochimistry of the transesterification step of ribonuclease T1. Biochemistry 11:3507–3512
Eckstein F, Simonson LP, Bär H-P (1974) Adenosine 3′,5′-cyclic phosphorothioate: Synthe sis and biological properties. Biochemistry 13:3806–3810
Egami F, Takahashi K, Uehida T (1964) Ribonuclease in taka-diastase: Properties, chemical nature, and applications. In: Davidson, Cohn (eds) Progress in nucleic acid research and molecular biology, Academic Press Inc, New York, vol 3, pp 59–101
Engels J (1979) Synthesis and reactivity of guanosine 3′,5′-phosphoric acid alkyl esters. Bioorg Chem 8:9–16
Engels J, Pfleiderer W (1975) Nucleotide, V: Synthese und Eigenschaften von Uridin-3′,5′-cyclophosphat-triestern. Tetrahedron Lett 1661–1664
Engels J, Schlaeger E-J (1977) Synthesis, structure, and reactivity of adenosine cyclic 3′,5′-phosphate benzyl triesters. J Med Chem 20:907–911
Epps D, Chang IM, Sherwood E, Kimball AP (1975) Feedback inhibition by 6-methyl-thioinosine 3′,5′-cyclic monophosphate in tumor cells resistant to the nucleoside. Proc Soc Exp Biol Med 150:578–580
Eto M, Iio M, Kobayashi Y, Omura H, Eto M (1974) Syntheses of ribonucleoside 5′-S-methyl phosphorothiolates and ribonucleoside 3′,5′-cyclic phosphates from nucleosides applying a new phosphorylating agent, MTBO. Agr Biol Chem 38:2081–2092
Eto M, Iio M, Omura H, Eto M (1978) Direct synthesis of ribonucleoside 2′,3′-cyclic phosphate from ribonucleoside. Agr Biol Chem 42:199–200
Evans DB, Parham CS, Schenck MT, Laffan RJ (1976) Stimulation of myocardial contractility by a new cyclic nucleotide analog, 8-(benzylthio)-N6-n-butyladenosine cyclic 3′,5′-phosphate (SQ80122). J Cyclic Nucleotide Res 2:307–319
Falbriard J-G, Posternak T, Sutherland EW (1967) Preparation of derivatives of adenosine 3′,5′-phosphate. Biochim Biophys Acta 148:99–105
Fazakerley GV, Russell JC, Wolfe M (1975) Conformation of the gadolinium complexes of adenosine 3′,5′-cyclic monophosphoric acid and inosine 3′,5′-cyclic monophosphoric acid. J Chem Soc Chem Commun 527
Fazakerley GV, Russell JC, Wolfe MA (1977) Determination of the syn-anti equilibrium of some purine 3′:5′-nucleotides by nuclear-magnetic-relaxation perturbation in the presence of a lanthanide-ion probe. Eur J Biochem 76:601–605
Fikus M, Welfeld JK, Kazimierczuk Z, Shugar D (1974) Biochemical studies on some new analogues of adenosine-3′,5′-cyclic phosphate, including isoguanosine-3′,5′-cyclic phosphate. Acta Biochim Pol 21:465–474
Fischer E (1914) Über Phosphorsäureester des Methyl-glucosids und Theophyllin-gluco-sids. Chem Ber 47:3193–3205
Forrest HS, Todd AR (1950) Nucleotides. Part V. Riboflavin 5′-phosphate. J Chem Soc 3295–3299
Fox JJ, Miller NC (1963) Nucleosides. XVI. Further studies of anhydronucleosides. J Org Chem 28:936–941
Free CA, Paik VS (1977) Adrenal steroidogenic actions of cyclic nucleotide derivatives in the rat. Endocrinology 100:1287–1293
Friedman DL (1976) Role of cyclic nucleotides in cell growth and differentiation. Physiol Rev 56:652–708
Friedman RM (1977) Antiviral activity of interferons. Bacteriol Rev 41:543–567
Friedman RM (1978 a) Interferons and cancer. J Natl Cancer Inst 60:1191–1194
Friedman RM (1978 b) Interferon action and the cell surface. Pharmacol Ther pt A, 2:425–438
Friedman RM, Pastan I (1969) Interferon and cyclic-3′,5′-adenosine monophosphate: potentiation of antiviral activity. Biochem Biophys Res Commun 36:735–740
Friedrich VW (1963) Zur Kenntnis der Phosphorsäureester der Benzimidazolriboside. Z Naturforsch 186:455–462
Fujimoto Y, Naruse M (1968) Nucleoside 3′,5′-cyclic phosphates. Japanese Patent 68 16,988
Fürth JJ, Cohen SS (1967) Inhibition of mammalian DNA Polymerase by the 5′-triphos-phate of 9-β-D-arabinofuranosyladenine. Cancer Res 27:1528–1533
Fuse A, Kuwata T (1978) Inhibition of DNA synthesis and alteration of cyclic adenosine 3′,5′-monophosphate levels in RSa cells by human leukocyte interferon. J Natl Cancer Inst 60:1227–1232
Garbers DL, Suddath JL, Hardman JG (1975) Enzymatic formation of inosine 3′,5′-mono-phosphate and of 2′-deoxyguanosine 3′,5′-monophosphate. Inosinate and deoxyguany-late cyclase activity. Biochim Biophys Acta 377:174–185
Gassen HG, Witzel H (1967) Zum Mechanismus der Ribonuclease-Reaktion. 1. Die Aufgabe der Pyrimidinbase bei der Reaktion. Eur J Biochem 1:36–45
Geahlen RL, Haley BE, Krebs EG (1979) Synthesis and use of 8-azidoguanosine 3′,5′-cyclic monophosphate as a photoaffmity label for cyclic GMP-dependent protein kinase. Proc Natl Acad Sci USA 76:2213–2217
Gericke D, Chandra P (1969) Inhibition of tumor growth by nucleoside cyclic 3′,5′-mono-phosphates. Hoppe-Seylers Z Physiol Chem 350:1469–1471
Gerlt JA, Gutterson NI, Datta P, Belleau B, Penney CL (1980a) Thermochemical identification of the structural factors responsible for the thermodynamic instability of 3′,5′-cyclic nucleotides. J Am Chem Soc 102:1655–1660
Gerlt JA, Gutterson NI, Drews RE, Sokolow JA (1980b) Conformational properties of 5-alkoxy and 5-alkyl substituted trimethylene phosphates in solution. J Am Chem Soc 102:1665–1670
Gerlt JA, Westheimer FH, Sturtevant JM (1975) The enthalpies of hydrolysis of acyclic, monocyclic, and glycoside cyclic phosphate diesters. J Biol Chem 250:5059–5067
Gerster JF, Hinshaw BC, Robins RK, Townsend LB (1968) Purine nucleosides. XIX. The synthesis of certain 8-chloropurine nucleosides and related derivatives. J Org Chem 33:1070–1073
Gerster JF, Robins RK (1966) Purine nucleosides XIII. The synthesis of 2-fluoro and 2-chloroinosine and certain derived purine nucleosides. J Org Chem 31:3258–3262
Giarrusso FF, Robins RK, unpublished results
Gillen RG, Nagyvary J (1976) Some biochemical properties of alkyl phosphotriesters of cyclic AMP. Biochem Biophys Res Commun 68:836–840
Gibson DW, Beer M, Barrnett RJ (1971) Gold (III) complexes of adenine nucleotides. Biochemistry 10:3669–3679
Glaudemans CPJ, Fletcher HG Jr (1963) Syntheses with partially benzylated sugars. III. A simple pathway to a “ds-nucleoside,” 9-β-D-arabinofuranosyladenine (spongo-adenosine). J Org Chem 28:3004–3006
Gohil RN, Gillen RG, Nagyvary J (1974) Synthesis and properties of some cyclic AMP alkyl phosphotriesters. Nucleic Acids Res 1:1691–1701
Goldberg ML, Burke GC, Morris HP (1975 a) Cyclic AMP and cyclic GMP content and binding in malignancy. Biochem Biophys Res Commun 62:320–327
Goldberg ND, Dietz SB, O’Toole AG (1969) Cyclic guanosine 3′,5′-monophosphate in mammalian tissues and urine. J Biol Chem 244:4458–4466
Goldberg ND, Haddox MK (1977) Cyclic GMP metabolism and involvement in biological regulation. Annu Rev Biochem 46:823–896
Goldberg ND, Haddox MK, Nicol SE, Glass DB, Sanford CH, Kuehl FA Jr, Estensen R (1975) Biologic regulation through opposing influences of cyclic GMP and cyclic AMP: The yin yang hypothesis. Adv Cyclic Nucleotide Res 5:307–330
Goldberg ND, O’Dea RF, Haddox MK (1973) Cyclic GMP. Adv Cyclic Nucleotide Res 3:155–223
Gorenstein DG (1975) Dependence of 31P chemical shifts on oxygen-phosphorus-oxygen bond angles in phosphate esters. J Am Chem Soc 97:898–900
Greengard P (1971) On the reactivity and mechanism of action of cyclic nucleotides. Ann NY Acad Sci 185:18–26
Greengard P, Paoletti R, Robison GA (1972) Adv Cyclic Nucleotide Res 1,2
Greengard P, Rudolph SA, Sturtevant JM (1969) Enthalpy of hydrolysis of the 3′ bond of adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate. J Biol Chem 244:4798–4800
Gresser I (1977) On the varied biologic effect of interferon. Cell Immunol 34:406–415
Gresser I, DeMaeyer-Guignard J, Tovey MG, DeMaeyer E (1979) Electrophoretically pure mouse interferon exerts multiple biologic effects. Proc Natl Acad Sci USA 76:5308–5312
Grollman EF, Lee G, Ramos S, Lazo PS, Kaback HR, Friedman RM, Kohn LD (1978) Relationships of the structure and function of the interferon receptor to hormone receptors and establishment of the antiviral state. Cancer Res 38:4172–4185
Guilford H, Larsson P-O, Mosbach K (1972) On adenine nucleotides for affinity chromatography. Chimica Scripta 2:165–170
Gulyaev NN, Baranova LA, Severin ES (1976) Adenosine-3′,5′-cyclosulfate for selective regulation of the level of adenosine-3′,5′-cyclophosphate in cell. U.S.S.R. Patent 502,887. Chem Abstr 84:136012x
Gulyaev NN, Tunitskaya VL, Nesterova MV, Mazurova LA, Murtuzaev IM, Severin ES (1977) Interaction of 8-substituted derivatives and adenosine-3′,5′-cyclophosphate es ters with protein kinase from pig brain. Biokhimiya (Moscow) 42:2071–2078
Haake PC, Westheimer FH (1961) Hydrolysis and exchange in esters of phosphoric acid. J Am Chem Soc 83:1102–1113
Haga K, Kainosho M, Yoshikawa M (1971) Studies of phosphorylation. V. The synthesis of inosine-5′-thiophosphates. Bull Chem Soc (Japan) 44:460–463
Hall DA, Barnes LD, Dousa TP (1977) Cyclic AMP in action of antidiuretic hormone: effects of exogenous cyclic AMP and its new analogue. Am J Physiol 232F:368–376
Halprin KM (1976) Cyclic nucleotides and epidermal cell proliferation. J Invest Dermatol 66:339–343
Hampton A, Brox LW, Bayer M (1969) Analogs of inosine 5′-phosphate with phosphorus-nitrogen and phosphorus-sulfur bonds. Binding and kinetic studies with inosine 5′-phosphate dehydrogenase. Biochemistry 8:2303–2311
Hanze AR (1967) Deazapurine riboside cyclic 3′,5′-phosphates and process therefor. US Patent 3,300,479
Hanze AR (1968) Nucleic Acids. V. Nucleotide derivatives of tubercidin (7-deazaadenosine). Biochemistry 7:932–939
Haque M, Caughlan CN, Moats WL (1970) The crystal and molecular structure of propane-1,3-diol cyclic phosphate (C3H7PO4). J Org Chem 35:1446–1448
Hardman JG, Davis JW, Sutherland EW (1966) Measurement of guanosine 3′,5′-mono-phosphate and other cyclic nucleotides. J Biol Chem 241:4812–4815
Hardman JG, Davis JW, Sutherland EW (1969) Effects of some hormonal and other factors on the excretion of guanosine 3′,5′-monophosphate and adenosine 3′,5′-monophos-phate in rat urine. J Biol Chem 244:6354–6362
Hardman JG, Robison GA, Sutherland EW (1971) Cyclic nucleotides. Annu Rev Physiol 33:311–336
Hardman JG, Sutherland EW (1965) A cyclic 3′,5′-nucleotide phosphodiesterase from heart with specificity for uridine 3′,5′-phosphate. J Biol Chem 240:3704–3705
Hardman JG, Sutherland EW (1969) Guanyl cyclase, an enzyme catalyzing the formation of guanosine 3′,5′-monophosphate from guanosine triphosphate. J Biol Chem 244:6363–6370
Hashimoto J, Uchida T, Egami F (1970) Action of ribonucleases T1 T2, and U2 on dinucleoside monophosphates containing 7-deazapurine base. Biochim Biophys Acta 199:535–536
Hayaishi O, Greengard P, Colowick SP (1971) On the equilibrium of the adenylate cyclase reaction. J Biol Chem 246:5840–5843
Hemmes P, Oppenheimer L, Jordan F (1976) Ultrasonic relaxation evidence for a two-state glycosyl conformational equilibrium in aqueous solution of adenosine 3′,5′-cyclic monophosphate. J Chem Soc Chem Commun 929–930
Hevesi L, Davidson EW, Nagy JB, Nagy OB, Bruglants A (1972) Contribution to the mechanism of the acid-catalyzed hydrolysis of purine nucleosides. J Am Chem Soc 94:4715–4720
Hirata M, Hayaishi O (1966) Enzymatic formation of deoxyadenosine 3′,5′-phosphate. Bio-chem Biophys Res Commun 24:360–364
Hoffman DJ, Whistler RL (1968) Diabetogenic action of 5-thio-D-glucopyranose in rats. Biochemistry 7:4479–4482
Hoffman DJ, Whistler RL (1970) Synthesis and properties of nucleotides containing 4-thio-D-ribofuranose. Biochemistry 9:2367–2372
Hofmann F, Flockerzi V, Schwechheimer K, Speichermann N (1979) Krause EG, Pinna L, Wollenberger A (eds) In: Studies on the activation mechanism of cyclic nucleotide-de-pendent protein kinases. FEBS 12 th Meeting, Dresden, 1978, vol 54, Symposium 7: Cyclic Nucleotides and Protein Phosphorylation in Cell Regulation. Pergamon Press, London, New York, p 115
Höfle G, Steglich W (1972) 4-Dialkylaminopyridines as acylation catalysts; III. Acylation of sterically hindered alcohols. Synthesis 619–621
Holmes RE, Robins RK (1964) Purine nucleosides. VII. Direct bromination of adenosine, deoxyadenosine, guanosine, and related purine nucleosides. J Am Chem Soc 86:1242–1245
Holý A (1969a) Oligonucleotidic compounds. XXX. Synthesis of some 5′-O-substituted derivatives of guanosine 2′,3′-cyclic phosphate and guanylyl-(3′,→5′)-uridine. Coll Czech Chem Commun 34:1261–1277
Holý A (1969b) Nucleic acid components and their analogues. CXXVIII. Phosphorylation of some thymine 1-pentopyranosyl and 1-hexopyranosyl derivatives by the reaction with triethyl phosphite and hexachloroacetone. Coll Czech Chem Commun 34:3510–3522
Holý A (1970a) Oligonucleotidic compounds. XXXVIII. Synthesis of diribonucleoside phosphates and triribonucleoside diphosphates derived from adenosine 3′-phosphate and guanosine 3′-phosphate: A general approach to the synthesis of oligonucleotides. Coll Czech Chem Commun 35:3686–3711
Holý A (1970b) Nucleic acid components and their analogues. CXXX. Preparation of nu-cleotide derivatives of 1′-homouridine and their behaviour towards some nucleolytic enzymes. Coll Czech Chem Commun 35:81–88
Holý A, Bald RW (1971) Nucleic acid components and their analogues. CXXXVIII. Synthesis of 2′,3′-cyclic phosphates derived from some pyrimidine ribonucleosides and their behaviour towards pancreatic ribonuclease and ribonuclease T2. Coll Czech Chem Commun 36:2809–2823
Holý A, Bald RW, Hong NgD (1971) Nucleic acid components and their analogues. CXXXVII. Preparation and properties of some N-(2-hydroxyethyl) derivatives of ribonucleosides and nucleotides. Coli Czech Chem Commun 36:2658–2676
Holý A, Chlädek S, Zemlicka J (1969) Oligonucleotidic compounds. XXIX. Reactions of ribonucleoside 2′(3′)-phosphates with dimethylformamide acetals. Coll Czech Chem Commun 34:253–271
Holý A, Smrt J (1966) Oligonucleotide compounds. XL Synthesis of ribonucleoside-2′,3′ cyclophosphates from nucleosides via nucleoside 2′,3′-phosphites. Coll Czech Chem Commun 31:1528–1534
Holý A, Smrt J, Šorm F (1965) Nucleic acids components and their analogues. LXXI. Oxidation of nucleoside 5′-phosphates on treatment with halo acid derivatives and hexachloroacetone. Coll Czech Chem Commun 30:3309–3319
Holy A, ′orm F (1966) Nucleic acids components and their analogues. LXXXI. A selective synthesis of ribonucleoside-2′(3′) phosphites. Coll Czech Chem Commun 31:1562–1568
Holy A, Sorm F (1969) Oligonucleotidic compounds. XXXII. Phosphorylation of 1-lyxo-furanosyl, 1-xylofuranosyl and 1-arabinofuranosyl derivatives of uracil and thymine with triethyl phosphite and hexachloroacetone. Coll Czech Chem Commun 34:1929–1953
Holy H, Ivanova GS (1974) Aliphatic analogues of nucleotides: synthesis and affinity towards nucleases. Nucleic Acids Res 1:19–34
Hong CI, Tritsch GL, Mittelman A, Hebborn P, Chheda GP (1975) Synthesis and antitumor activity of 5′-phosphates and cyclic 3′,5′-phosphates derived from biologically active nucleosides. J Med Chem 18:465–473
Honjo M, Furukawa Y, Yoshioka Y, Imada A, Fujii S, Ootsu K, Kimura T, Komeda T, Matsumoto T (1968) Synthesis of 6-mercaptopurine 2′-deoxyribonucleoside and its related compounds and their biological activities. Ann Rep Takeda Res Lab 27:1–19
Honjo M, Marumoto R, Yoshioka Y, Takatsuki S (1973) 2-Substituted adenosine 3′,5′-cyclomonophosphates. Ger Offen 2,324,130
Hoppe J, Wagner KG (1974) Synthesis and properties of N6,C-8 and C-2 spin-labelled derivatives of adenosine cyclic 3′,5′-monophosphate. Eur J Biochem 48:519–525
Hsie AW, Puck TT (1971a) Morphological transformation of Chinese hamster cells by dibutyryl adenosine cyclic 3′,5′-monophosphate and testosterone. Proc Natl Acad Sci USA 68:358–361
Hsie AW, Janes C, Puck TT (1971 b) Further changes in differentiation state accompanying the conversion of Chinese hamster cells to fibroblastic form by dibutyryl adenosine cyclic 3′:5′-monophosphate and hormones. Proc Natl Acad Sci USA 68:1648–1652
Hubert-Habart M, Goodman L (1969) The direct formation of a 3′,5′-cyclic mononu-cleotide from an adenine nucleoside. J Chem Soc Chem Commun 740–741
Hutchinson DW (1971) Phosphates and phosphonates of biochemical interest. In: Trippett (ed) Organophosphorus chemistry, vol 2. John Wright and Sons Ltd, Bristol, pp 119–155
Hwang TC, Clark VL, Bernlohr RW (1974) Guanosine 3′,5′-cyclic monophosphate phosphodiesterase activity of Bacillus Licheniformis. Biochem Biophys Res Commun 58:707–713
Ikehara M, Harada F, Ohtsuka E (1966) Polynucleotides. III. Synthesis of four trinucleoside diphosphates containing tubercidin (7-deazaadenosine) and N6-dimethyl-adenosine. Chem Pharm Bull (Tokyo) 14:1338–1346
Ikehara M, Muneyama K (1967) Studies of nucleosides and nucleotides. XXXIV. Purine cyclonucleosides. 4. Synthesis of a cyclonucleoside having an O cyclo linhage derived from guanosine. J Org Chem 32:3039–3042
Ikehara M, Ohtsuka E (1963 a) Studies on coenzyme analogs. XVI. Synthesis of 9-D-erythrityladenine and its phosphates. Chem Pharm Bull (Tokyo) 11:1095–1101
Ikehara M, Ohtsuka E (1963 b) Studies on coenzyme analogs. XIX. Further investigations of phosphorylation using morpholinophosphorodicholoridate and P1-diphenyl P2-morpholino pyrophosphorochloridate. Chem Pharm Bull (Tokyo) 11:1353–1358
Ikehara M, Ohtsuka E (1963 c) Studies of nucleosides and nucleotides. XXI. A new synthesis of thymidine 5′-triphosphate and the use of P1,P2-di-(2-cyanoethyl)-pyrophosphate in the nucleoside triphosphate synthesis. Chem Pharm Bull (Tokyo) 11:1358–1363
Ikehara M, Tazawa I (1966) Studies of nucleosides and nucleotides. XXIX. Direct synthesis of nucleoside-2′,3′-cyclic phosphates. J Org Chem 31:819–821
Ikehara M, Uesugi S (1969) Studies of nucleosides and nucleotides. XXXVIII. Synthesis of 8-bromoadenosine nucleotides. Chem Pharm Bull (Tokyo) 17:348–354
Ikehara M, Uesugi S (1972) Studies of nucleosides and nucleotides. LIII. Purine cyclonucleosides-18. Selective tosylation of adenine nucleotides. Synthesis of 8,2′-anhydro-8-mercapto-9-β-D-arabinofuranosyladenine 5′-and 3′,5′-cyclic phosphate. Tetrahedron 28:3687–3694
Ikehara M, Uesugi S, Kaneko M (1967) Bromination of adenine nucleoside and nucleotide. J Chem Soc Chem Commun 17–18
Ikehara M, Uesugi S, Kaneko M (1978) 8-Bromoadenosine and its 5′-phosphate. Nucleic acid chem., improved and new synthetic procedures, methods, and techniques. Townsend, Tipson (eds) John Wiley and Sons, New York, pt 2 p 837–841
Imai K, Fujii S, Takanohashi K, Furukawa Y, Masuda T, Honjo M (1969) Studies on phosphorylation. IV. Selective phosphorylation of the primary hydroxyl group in nucleosides. J Org Chem 34:1547–1550
Imai K, Marumoto R, Kobayashi K, Yoshioka Y, Toda J, Honjo M (1971) Synthesis of compounds related to inosine 5′-phosphate and their flavor enhancing activity. IV. 2-Substituted inosine 5′-phosphates. Chem Pharm Bull (Tokyo) 19:576–586
Imai S, Otorii T, Takeda K, Katano Y, Horii D (1974) Effects of cyclic AMP and dibutyryl cyclic AMP on the heart and coronary circulation. Jpn J Pharmacol 24:499–510
Inagaki F, Takahashi S, Tasumi M, Miyazawa T (1976) Conformation of thymidine 3′,5′-cyclic phosphate in aqueous solution. Compatibility of the information from the lan-thanide-ion probe and the spin-coupling constants. Bull Chem Soc (Jpn) 49:611–616
Ingemarsson S, Cantell K, Strander H (1979) J Infect Dis 140:560
Ishikawa E, Ishikawa S, Davis JW, Sutherland EW (1969) Determination of guanosine 3′,5′-monophosphate in tissues and of guanyl cyclase in rat intestine. J Biol Chem 244:6371–6376
Ishiyama J (1975) Isolation of cyclic 3′,5′-pyrimidine mononucleotides from bacterial culture fluids. Biochem Biophys Res Commun 65:286–292
Ishiyama J (1976) Isolation of cyclic deoxyadenosine 3′,5′-monophosphate from the culture fluid of Corynebacterium murisepticum No 7. J Biol Chem 251:438–440
Ishiyama J, Yokotsuka T, Saito N (1974) Cyclic-AMP production by Corynebacterium murisepticum No 7 (ATCC 21374) and Microbacterium sp. No 205 (ATCC 21376). Agr Biol Chem 38:507–514
Jardetzky CD (1962) Proton magnetic resonance of nucleotides. IV. Ribose conformation. J Am Chem Soc 84:62–66
Jastorff B, Bär H-P (1973) Effects of 5′-amido analogues of adenosine 3′,5′-monophosphate and adenosine 3′,5′-monophosphothioate on protein kinase, binding protein and phosphodiesterases. Eur J Biochem 37:497–504
Jastorff B, Freist W (1972) New analogs of adenosine-3′,5′-cyclophosphate. Angew Chem (Engl) 11:713
Jastorff B, Freist W (1974) Synthesis and biological activities of cyclic AMP analogs modified in the 1,2 and 2′-positions. Bioorg Chem 3:103–113
Jastorff B, Hoppe J, Morr M (1979) A model for the chemical interactions of adenosine 3′,5′-monophosphate with the R subunit of protein kinase type I. Refinement of the cyclic phosphate binding moiety of protein kinase type I. Eur J Biochem 101:555–561
Jastorff B, Krebs T (1972) Analoge des Adenosin-(3′.5′)-cyclophosphats mit Stickstoff und Schwefelatomen im Phosphatring. Chem Ber 105:3192–3202
Jastorff B, Krebs T (1974) Amidocyclothiophosphates. Ger Offen 2,247,782
Jergil B, Guilford H, Mosbach K (1974) Biospecific affinity chromatography of an adenosine 3′,5′-cyclic monophosphate-stimulated protein kinase (Protamine kinase from trout testis) by using immobilized adenine nucleotides. Biochem J 139:441–448
Jergil B, Mosbach K (1974) Cyclic AMP: Purification of protamine kinase. Methods Enzymol 34:261–264
Johnson GS, Friedman RM, Pastan I (1971) Restoration of several morphological characteristics of normal fibroblasts in sarcoma cells treated with adenosine-3′,5′-cyclic monophosphate and its derivatives. Proc Natl Acad Sci USA 68:425–429
Johnson LD, Hadden JW (1977) Modification of human DNA-dependent RNA polymerase activity by cyclic GMP. Nucleic Acids Res 4:4007–4014
Johnson RA, Walseth TF (1979) The enzymatic preparation of [α-32P]ATP, [α-32P]GTP, [32P]cAMP, and [32P]cGMP, and their use in the assay of adenylate and guanylate cyclases and cyclic nucleotide phosphodiesterases. Adv Cyclic Nucleotide Res 10:135–167
Jones GH, Albrecht HP, Damodaran NP, Moffatt JG (1970) Synthesis of isosteric phosphonate analogs of some biologically important phosphodiesterases. J Am Chem Soc 92:5510–5511
Jones GH, Moffatt JG (1968) The synthesis of 6′-deoxy-homonucleoside-6′-phosphonic acids. J Am Chem 90:5337–5338
Jones GH, Moffatt JG (1969) 3′-Cyclic esters of 5′-deoxy-5′dihydroxyphosphinylmethyl)-nucleosides. US Patent 3,446,793
Jones GH, Moffatt JG (1974) Cyclic phosphoric acid ester of 1,N6-ethenoadenosines. Ger Offen 2,350,608
Jones GH, Moffatt JG (1975) 1,N6-Ethenoadenosine cyclophosphate compounds. US Patent 3,872,098
Jones GH, Murthy DVK, Tegg D, Golling R, Moffatt JG (1973) Analogs of adenosine 3′,5′-cyclic phosphate. IL Synthesis and enzymatic activity of derivatives of 1,N6-ethenoadenosine 3′,5′-cyclic phosphate. Biochem Biophys Res Commun 53:1338–1343
Jones GH, Ranganathan RS, Moffatt JG (1975) Purine nucleoside 3′,5′-cyclic phosphates. US Patent 3,872,084
Jordan F (1973) The electronic structure of and conformational energy barrier to rotation around the C-N glycosidic linkage in adenosine-3′,5′-cyclicmonophosphate (cyclic AMP) and its phosphonate analog. J Theor Biol 41:23–40
Jurovcik M, Holý A, Šorm F (1971) The utilization of l-adenosine by mammalian tissues. FEBS Lett 18:274–276
Kainosho M, Ajisaka K (1975) Conformational study of cyclic nucleotides. Lanthanide ion assisted analysis of the hydrogen-1 nuclear magnetic resonance spectra. J Am Chem Soc 97:6839–6843
Kaiser ET, Lee TWS, Boer FP (1971) Structure and enzymatic reactivity of an aromatic five-membered cyclic phosphate diester. Biological implications. J Am Chem Soc 93:2351–2353
Kanai T, Ichino M, Hoshi A, Kuretani K (1971) Some phosphate esters of cyclocytidine and aracytidine. Tetrahedron Lett 1965–1968
Karpeiskii MYa, Yakovleve GI (1975) Nuclear Overhauser effect study on base and sugar relative arrangement in aqueous solutions of cytidine nucleotides. Bioorg Khim 1:749–757
Kavunenko AP, Holý A (1978) Acceptor activity of uracil nucleosides in the dinucleoside monophosphate synthesis catalyzed by pancreatic ribonuclease. Nucleic Acids Res Spe Publ 4:sl43–146
Kawana M, Ivanovics GA, Rousseau RJ, Robins RK (1972) Azapurine nucleosides. 3. Synthesis of 7-(β-D-ribofuranosyl)imidazo[4,5-d]-v-triazin-4-one (2-azainosine) and related derivatives. J Med Chem 15:841–843
Kawanabe T, Machida M (1976) Cyclic phosphoric acid esters of 1,N6-ethenoadenosines. Ger Offen 2,365,720
Kazimierczuk Z, Shugar D (1973) Preparative photochemical synthesis of isoguanosine ribo-and deoxyribonucleosides and nucleotides, and isoguanosine-3′,5′-cyclic phosphate, a new cAMP analogue. Acta Biochim Pol 20:395–402
Khorana HG (1961 a) Cyclic phosphate formation and its role in the chemistry of phosphate esters of biological interest. In: Some recent developments in the chemistry of phosphate esters of biological interest. John Wiley and Sons, Inc. New York, pp 44–68
Khorana HG (1961 b) Phosphodiesterases. In: Boyer PD, Lardy H, Myrbäck K (eds) Enzymes. Academic Press, New York, pp 79–94
Khorana HG, Vizsolyi JP (1961) Studies on polynucleotides. VIII. Experiments on the polymerization of mononucleotides. Improved preparation and separation of linear thymidine polynucleotides. Synthesis of corresponding members terminated in deoxycytidine residues. J Am Chem Soc 83:675–685
Khorana HG, Turner AF, Vizsolyi JP (1961) Studies on polynucleotides. IX. Experiments on the polymerization of mononucleotides. Certain protected derivatives of deoxy-cytidine-5′ phosphates and the synthesis of deoxycytidine polynucleotides. J Am Chem Soc 83:686–698
Khorana HG, Tener GM, Wright RS, Moffatt JG (1957) Cyclic phosphates. III. Some general observations on the formation and properties of five-, six-and seven-membered cyclic phosphate esters. J Am Chem Soc 79:430–436
Khwaja TA, Boswell KH, Robins RK, Miller JP (1975) 8-Substituted derivatives of adenosine 3′,5′-cyclic phosphate require an unsubstituted 2′-hydroxyl group in the ribo configuration for biological activity. Biochemistry 14:4238–4244
Khwaja TA, Harris R, Robins RK (1972) Synthesis of 9-β-D-arabinofuranosyladenine-3′,5′-cyclic phosphate from adenosine-3′,5′-cyclic phosphate. Tetrahedron Lett 4681–4684
Khwaja TA, Kigwana L, Robins RK (1974) Nucleoside 3′,5′-cyclic phosphates as antitumor agents. Proc Am Assoc Cancer Res 15:94. Abstr 373
Khwaja TA, Robins RK (1979) Personal communication
Kikkoman Shoyu Company (1971a) 3′,5′-Cyclic adenylic acid production. US Patent 3,630,842
Kikkoman Shoyu Company (1971b) 3′,5′-Cyclic deoxyadenylic acid. Japanese Patent 71 42,958
Kimura H, Murad F (1974) Nonenzymatic formation of guanosine 3′,5′-monophosphate from guanosine triphosphate. J Biol Chem 249:329–331
Kishi T, Muroi M, Kusaka T, Nishikawa M, Kamiya K, Mizuno K (1967) The structure of aristeromycin. J Chem Soc Chem Commun 852–853
Klee WA, Mudd SH (1967) The conformation of ribonucleosides in solution. The effect of structure on the orientation of the base. Biochemistry 6:988–998
Klein RS, Wempen I, Watanabe KA, Fox JJ (1970) Nucleosides. LXVII. The chemistry of 4-methyl-2-pyrimidinone ribonucleosides. J Org Chem 35:2330–2334
Kneer NM, Bosch AL, Clark MG, Lardy HA (1974) Glucose inhibition of epinephrine stimulation of hepatic gluconeogenesis by blockade of the α-receptor function. Proc Natl Acad Sci USA 71:4523–4527
Kobata A, Kida M, Ziro S (1961) Occurrence of 3′,5′-cyclic AMP in milk. J Biochem 50:275–276
Koblet H, Wyler R, Kohler U (1978) Kinetics of interferon action. Experientia 34:1164–1165
Koblet H, Wyler R, Kohler U (1979) Increase of interferon antiviral activity by exogenous cyclic adenosine3′,5′-monophosphate (cAMP). Experientia 35:575–576
Kochetkov NK, Budovskii EI, Sverdlov ED, Simukova NA, Turchinskii MF, Shibaev VN (1972) Cleavage of phosphoester bonds and some other reactions of phosphate groups of nucleic acids and their components. In: Kochetkov, Budovskii (eds) Organic chemistry of nucleic acids, Part B, Plenum Press, London
Koontz JW, Wicks WD (1977) Inhibition of human granulocyte function by methotrexate. Cancer Res 37:651–655
Kreis W, Wechter WJ (1972) Studies on drug resistance. IV. Synthesis and biological activities of 1-β-D-arabinofuranosylcytosine 3′,5′-cyclic monophosphate and a derivative. Res Commun Chem Pathol Pharmacol 4:631–640
Kreis W, Wechter WJ (1972) Biological activity of 3′,5′-cyclic phosphates of 1-β-D-arabino-furanosylcytosine (arc-C). Proc Am Assoc Cancer Res 13:62
Kukovetz WR, Poch G (1970) Cardiostimulatory effects of cyclic 3′,5′-adenosine monophosphate and its acylated derivatives. Naunyn-Schmiedebergs Arch Pharmakol 266:236–254
Kumamoto J, Cox JR Jr, Westheimer FH (1956) Barium ethylene phosphate. J Am Chem Soc 78:4858–4860
Kung W, Marsh RE, Kainosho M (1977) Crystal and solution structure of 2′,5′-arabinosyl-cytidine monophosphate. Influence of POC bond angles on the protonphosphorus vicinal coupling constants in the P-O-C-H fragments. J Am Chem Soc 99:5471–5477
Kuo JF, Brackett NL, Shoji M, Tse J (1978) Cytidine 3′:5′-monophosphate phosphodiesterase in mammalian tissues. J Biol Chem 253:2518–2521
Kuo JF, Greengard P (1969) Cyclic nucleotide-dependent protein kinases. IV. Widespread occurrence of adenosine 3′,5′-monophosphate-dependent protein kinase in various tissues and phyla of the animal kingdom. Proc Natl Acad Sci USA 64:1349–1355
Kuo JF, Krueger BK, Sanes JR, Greengard P (1970) Cyclic nucleotide-dependent protein kinases. V. Preparation and properties of adenosine 3′,5′-monophosphate-dependent protein kinase from various bovine tissues. Biochim Biophys Acta 212:79–91
Kura G, Ohashi S (1971) Chromatographic separation of cyclic phosphates by means of an anion-exchange dextran gel. J Chromatogr 56:111–120
Lapinet E, Cehovic G, Posternak T (1971) New cosmetic compositions intended for the physiological care of human skin, hair and nails. French Patent 7,004,557
Lapper RD, Mantsch HH, Smith ICP (1972) A carbon-13 and hydrogen-1 nuclear magnetic resonance study of the conformations of 3′,5′-and 2′,3′-cyclic nucleotides. A demonstration of the angular dependence of three-bond spin-spin couplings between carbon and phosphorus. J Am Chem Soc 94:6243–6244
Lapper RD, Mantsch HH, Smith ICP (1973) A carbon-13 nuclear magnetic resonance study of the conformations of 3′,5′-cyclic nucleotides. J Am Chem Soc 95:2878–2880
Lapper RD, Smith ICP (1973) A 13C and 1H nuclear magnetic resonance study of the conformations of 2′,3′-cyclic nucleotides. J Am Chem Soc 95:2880–2884
Lavallee DK, Coulter CL (1973) Structural chemistry of cyclic nucleotides. III. Proton magnetic resonance studies of β-pyrimidine nucleotides. J Am Chem Soc 95:576–581
Lavallee DK, Myers RB (1978) Role of the pyrimidine base in ribonuclease A hydrolysis of RNA. Determination of the conformation of cyclic β-cytidine 2′,3#x2032;-phosphate and cyclic β-uridine 2′,3′-phosphate in solution. J Am Chem Soc 100:3907–3912
Lavallee DK, Zeltmann AH (1974) Conformation of cyclic β-adenosine 3′,5′-phosphate in solution using the lanthanide shift technique. J Am Chem Soc 96:5552–5556
Lawson AM, Stillwell RN, Tacker MM, Tsuboyama K, McCloskey JA (1971) Mass spectrometry of nucleic acid components. Trimethylsilyl derivatives of nucleotides. J Am Chem Soc 93:1014–1023
Lee WW, Fisher LV, Goodman L (1971) 9-(β-D-Arabinofuranosyl)adenine 3′,5′-cyclic phosphate. J Heterocycl Chem 8:179–180
Lee CC, Schrier WH, Nagyvary J (1979) The enzymatic hydrolysis of the phosphate ester bond in some thionucleotides. Biochim Biophys Acta 561:223–231
Lee C-H, Sarma RH (1976) Aqueous solution conformation of rigid nucleosides and nucleotides. J Am Chem Soc 98:3541–3548
Lehninger AL (1975) Biochemistry. 2nd edn. Worth Publishers, New York, p 729
Leonard NJ, Laursen RA (1965) Synthesis of 3-β-D-ribofuranosyladenine and (3-β-D-ribofuranosyladenine)-5′-phosphate. Biochemistry 4:354–365
Leonov D, Elad D (1974) Ultraviolet-and γ-ray-induced reactions of nucleic acid constituents. Reactions of purines with ethers and dioxolane. J Org Chem 39:1470–1473
LePage GA, Hersh EM (1972) Cyclic nucleotide analogs as carcinostatic agents. Biochem Biophys Res Commun 46:1918–1922
Lespinasse JN, Vasilescu D (1974) Conformational analysis of a cyclic nucleotide: ′3′,5′-Adenosine monophosphate. A study based on the extended Hückel theory. Biopolymers 13:63–75
Lincoln TM, Flockhart DA, Corbin JD (1978) Studies on the structure and mechanism of activation of the guanosine 3′,5′-monophosphate-dependent protein kinase. J Biol Chem 253:6002–6009
Lipkin D, Cook WH, Markham R (1959 a) Adenosine-3′:5′-phosphoric acid: A proof of structure. J Am Chem Soc 81:6198–6203
Lipkin D, Markham R, Cook WH (1959 b) The degradation of adenosine-5′-triphosphoric acid (ATP) by means of aqueous barium hydroxide. J Am Chem Soc 81:6075–6080
Lipkin D, Talbert PT (1955) The base-catalysed conversion of yeast ribonucleic acid to cyclic phosphate esters. Chem Industry (Lond) 143
Lipkind GM (1976) Theoretical conformational analysis of cytidine 2′,3′-cyclophosphate. Mol Biol (Mosk) 10:490–493
Litchfield GJ, Shaw G (1971) Purines, pyrimidines, and imidazoles. Part XXXV. Potentiometric and spectroscopic studies of some imidazoles related to intermediates in the biosynthesis de novo of purine nucleotides. J Chem Soc C:817–820
Lo KW, Yip KF, Tsou KC (1975) Fluorometric assay of 2′,3′-cyclic adenosine monophosphate 3′-phosphohydrolase with 1,N6-etheno-2-aza-adenosine 2′,3′-monophosphate. J Neurochem 25:181–183
Lohrmann R, Khorana HG (1964) Studies on polynucleotides. XXXIV. The specific synthesis of C3′-C5′-linked ribooligonucleotides. New protected derivatives of ribonucleo-sides and ribonucleoside 3′-phosphates. Further synthesis of diribonucleoside phosphates. J Am Chem Soc 86:4188–4194
Lomax NR, Narayanan VL (1979) Chemical structures of interest to the Division of Cancer Treatment. National Cancer Institute, Drug Synthesis and Chemistry Branch, January, p4
Long RA, Robins RK (1978) 5-Bromouridine 3′,5′-cyclic monophosphate. Nucleic Acid Chemistry, Improved and New Synthetic Procedures, Methods and Techniques. Townsend, Tipson (eds) pt 2, John Wiley and Sons, New York, pp 817–819
Long RA, Szekeres GL, Khwaja TA, Sidwell RW, Simon LN, Robins RK (1972) Synthesis and antitumor and antiviral activities of 1-β-D-arabinofuranosylpyrimidine 3′,5′-cyclic phosphates. J Med Chem 15:1215–1218
MacCoss M, Ezra FS, Robins MJ, Danyluk SS (1977) Conformational characteristics of rigid cyclic nucleotides. 2. The solution conformation of β-nucleoside 3′,5′-cyclic monophosphates and the role of the 2′-hydroxyl group. J Am Chem Soc 99:7495–7502
MacCoss M, Ezra FS, Robins MJ, Danyluk SS (1978) Proton magnetic resonance studies of 9-(β-D-xylofuranosyl)adenine 3′,5′-cyclic monophosphate and 9-(β-D-arabino-furanosyl)adenine 2′,5′-cyclic monophosphate. Carbohydr Res 62:203–212
Maguire MH, Caredes FP, Gough GR (1974) Effects of the 3′,5′-cyclic phosphates of 2-methylthioadenosine, 2-chloroadenosine and adenosine on platelet aggregation. Experientia 30:922–924
Makabe O, Miyadera A, Kinoshita M, Umezawa S (1978) Cyclic phosphates of formycin. J Antibiot 31:456–467
Markham R (1957) The preparation and assay of cyclic nucleotides. Methods Enzymol 3:805–810
Markham R, Smith JD (1951) Structure of ribonucleic acid. Nature 168:406–408
Markham R, Smith JD (1952) The structure of ribonucleic acids. 1. Cyclic nucleotides produced by ribonuclease and by alkaline hydrolysis. Biochem J 52:552–557
Marsh FJ, Weiner P, Douglas JE, Kollman PA, Kenyon GL, Gerlt JA (1980) Theoretical calculations on the geometric destabilization of 3′,5′-and 2′,3′-cyclic nucleotides. J Am Chem Soc 102:1660–1665
Marumoto R, Honjo M (1975) Aristeromycin-3′,6′-cyclic phosphoric acid. Japan Kokai 75 40,590
Marumoto R, Nishimura T, Honjo M (1975) A new method for synthesis of nucleoside 3′,5′-cyclic phosphates. Cyclization of nucleoside 5′-trichloromethyl phosphonates. Chem Pharm Bull (Tokyo) 23:2295–2300
Marumoto R, Yoshioka Y, Naka T, Shima S, Miyashita O, Maki Y, Suzuki T, Honjo M (1979) Synthesis and enzymatic activity of adenosine 3′,5′-cyclic phosphate analogs. Chem Pharm Bull (Tokyo) 27:990–1003
Marx JL (1979) Interferon (II): Learning about how it works. Recent research is clarifying how interferon inhibits viral reproduction but its other actions are less well understood. Science 204:1293–1295
Masson A, Levy B, Malrieu JP (1970) Formaldéhyde: calcul de l’énergic dans l’état fondamental par une méthode de perturbation. Theoret Chim Acta 18:193–207
Mato JM, Jastorff B, Morr M, Konijn TM (1978) A model for cyclic AMP-chemoreceptor interaction in Dictyostelium discoideum. Biochim Biophys Acta 544:309–314
Meldolesi MF, Friedman RM, Kohn LD (1977) An interferon-induced increase in cyclic AMP levels precedes the establishment of the antiviral state. Biochem Biophys Res Commun 79:239–246
Meyer RB Jr (1979) Analogs of cyclic nucleotides. In: Wolff (ed) Burger’s medicinal chemistry, 4 th edn, part II, John Wiley and Sons Inc, New York, pp 1201–1224
Meyer RB Jr, Miller JP (1974) Analogs of cyclic AMP and cyclic GMP: General methods of synthesis and the relationship of structure to enzymic activity. Life Sci 14:1019–1040
Meyer RB Jr, Shuman DA (1975) 2-Substituted cyclic AMP derivatives. US Patent 3,917,583
Meyer RB Jr, Shuman DA, Robins RK (1973 a) Synthesis of purine nucleoside 3′,5′-cyclic phosphoramidates. Tetrahedron Lett 269–272
Meyer RB Jr, Shuman DA, Robins RK (1974 a) A new purine ring closure and the synthesis of 2-substituted derivatives of adenosine cyclic 3′,5′-phosphate. J Am Chem Soc 96:4962–4966
Meyer RB Jr, Shuman DA, Robins RK (1974 b) Phosphoramidates of 3′,5′-cyclic purine nucleotides. US Patent 3,852,267
Meyer RB Jr, Shuman DA, Robins RK, Bauer RJ, Dimmitt MK, Simon LN (1972) Synthesis and biological activity of several 6-substituted 9-β-D-Ribofuranosylpurine 3′,5′-cyclic phosphates. Biochemistry 11:2704–2709
Meyer RB Jr, Shuman DA, Robins RK, Miller JP, Simon LN (1973 b) Synthesis and enzymic studies of 5-aminoimidazole and N1-and N6-substituted adenine ribonucleoside cyclic 3′,5′-phosphates prepared from adenosine cyclic 3′,5′-phosphate. J Med Chem 16:1319
Meyer RB Jr, Stone TE, Heinzel FP (1978) Direct sulfhydrolysis of cyclic AMP: A one-step synthesis of the cyclic ribonucleotide of 6-mercaptopurine. J Heterocycl Chem 15:1511–1512
Meyer RB Jr, Stone TE, Ullman B (1979) 2′-O-Acyl-6-thioinosine cyclic 3′,5′-phosphates as prodrugs of thioinosinic acid. J Med Chem 22:811–815
Meyer RB Jr, Uno H, Robins RK, Simon LN, Miller JP (1975 a) 2-Substituted derivatives of adenosine and inosine cyclic 3′,5′-phosphates. Synthesis, enzymic activity, and analysis of the structural requirements of the binding locale of the 2-substituent on bovine brain protein kinase. Biochemistry 14:3315–3321
Meyer RB Jr, Uno H, Shuman DA, Robins RK, Simon LN, Miller JP (1975 b) The synthesis of 2,6-disubstituted-9-β-D-ribofuranosylpurine cyclic 3′,5′-phosphates and the selectivity of cAMP and cGMP-specific enzymes to substituents in these positions. J Cyclic Nucleotide Res 1:159–167
Mian AM, Harris R, Sidwell RW, Robins RK, Khwaja TA (1974) Synthesis and biological activity of 9-β-D-arabinofuranosyladenine cyclic 3′,5′-phosphate and 9-β-D-arabino-furanosylguanine cyclic 3′,5′-phosphate. J Med Chem 17:259–263
Mian AM, Long RA, Allen LB, Sidwell RW, Robins RK, Khwaja TA (1979) Synthesis and antitumor and antiviral activities of 1-β-D-arabinofuranosyl-2-amino-1,4(2H)imino-pyrimidine and its derivatives. J Med Chem 22:514–517
Michal F, Maguire MH, Gough G (1969) 2-Methylthioadenosine-5′-phosphate: a specific inhibitor of platelet aggregation. Nature 222:1073–1074
Michal G, Muehlegger K, Nelboeck M, Thiessen C, Weimann G (1974) Cyclophosphates. VI. Cyclophosphates as substrates and effectors of phosphodiesterase. Pharm Res Commun 6:203–252
Michelson AM (1958) Synthesis of nucleoside cyclic phosphates. Chem Ind 70–71
Michelson AM (1959) Polynucleotides. Part II. Homopolymers of cytidylic and pseudouridylic acid, copolymers with repeating subunits, and the stepwise synthesis of polyribonucleotides. J Chem Soc 3655–3669
Miller JP (1977) Cyclic nucleotide analogues. In: Cramer, Schultz (eds) Cyclic 3′,5′-nucleotides; mechanisms of action. John Wiley and Sons, New York, pp 77–105
Miller JP, Beck AH, Simon LN, Meyer RB Jr (1975 a) Induction of hepatic tyrosine aminotransferase in vivo by derivatives of cyclic adenosine 3′,5′-monophosphate. J Biol Chem 250:426–431
Miller JP, Boswell KH, Meyer RB Jr, Christensen LF, Robins RK (1980 a) Synthesis and enzymatic and inotropic activity of some new 8-substituted and 6,8-disubstituted derivatives of adenosine cyclic 3′,5′-monophosphates. J Med Chem 23:242–251
Miller JP, Boswell KH, Mian AM, Meyer RB Jr, Robins RK, Khwaja TA (1976) 2′-Derivatives of guanosine and inosine cyclic 3′,5′-phosphates. Synthesis, enzymic activity, and the effect of 8-substituents. Biochemistry 15:217–223
Miller JP, Boswell KH, Muneyama K, Simon LN, Robins RK, Shuman DA (1973 a) Synthesis and biochemical studies of various 8-substituted derivatives of guanosine 3′,5′-cyclic phosphate, inosine 3′,5′-cyclic phosphate, and xanthosine 3′,5′-cyclic phosphate. Biochemistry 12:5310–5319
Miller JP, Boswell KH, Muneyama K, Tolman RL, Scholten MB, Robins RK, Simon LN, Shuman DA (1973 b) Activity of tubercidin-, toyocamycin-, and sangivamycin-3′,5′-cyclic phosphates and related compounds with some enzymes of adenosine-3′,5′-cyclic phosphate metabolism. Biochem Biophys Res Commun 55:843–849
Miller JP, Christensen LF, Andrea TA, Meyer RB Jr, Kitano S, Mizuno Y (1978) Interaction of “aza” and “deaza” analogs of adenosine cyclic 3′,5′-phosphate with some enzymes of adenosine cyclic 3′,5′-phosphate metabolism: Evidence that the lone pair electrons of N-3 are involved in the binding of adenosine cyclic 3′,5′-phosphate to type II adenosine cyclic 3′,5′-phosphate-dependent protein kinase. J Cyclic Nucleotide Res 4:133–144
Miller JP, Robins RK (1976) The chemical modification of cyclic AMP and cyclic GMP. Ann Rep Med Chem 11:291–300
Miller JP, Robins RK, Christensen LF, Boswell KH, Meyer RB Jr, submitted to J Cyclic Nucleotide Res
Miller JP, Shuman DA, Scholten MB, Dimmitt MK, Stewart CM, Khwaja TA, Robins RK, Simon LN (1973 c) Synthesis and biological activity of some 2′-derivatives of adenosine 3′,5′-cyclic phosphate. Biochemistry 12:1010–1016
Miller JP, Yagura TS, Meyer RB Jr, Robins RK, Uno H (1980 b) Synthesis and enzymic studies of 2-substituted and 2-modified derivatives of 1,N6-ethenoadenosine cyclic 3′,5′-phosphate. J Carbohydr Nucleosides Nucleotides 7:167–184
Miller Z, Lovelace E, Gallo M, Pastan I (1975 b) Cyclic guanosine monophosphate and cellular growth. Science 190:1213–1215
Mitsugi K, Komagata K, Takahashi M, Iizuka H, Katagiri H (1964) Bacterial synthesis of nucleotides. Part II. Distribution of nucleoside phosphotransferase in bacteria. Agr Biol Chem 28:586–600
Mizuno Y, Kitano S, Nomura A (1975) Nucleotides. III. Synthesis of deazaadenosine 3′,5′-cyclic phosphates and related nucleotides of biological interest. Chem Pharm Bull (Tokyo) 23:1664–1670
Mizuno Y, Tazawa S, Kageura K (1968) Synthetic studies of potential antimetabolites. XII. Synthesis of 4-substituted 1-β-D-ribofuranosyl)-1H-imidazo[4,5-c]pyridines. Chem Pharm Bull (Tokyo) 16:2011–2017
Moens W, Vokaer A, Kram R (1975) Cyclic AMP and cyclic GMP concentrations in serum-and density-restricted Fibroblast cultures. Proc Natl Acad Sci USA 72:1063
Montgomery JA, Thomas HJ (1961) Synthesis of potential anticancer agents. XXVII. The ribonucleotides of 6-mercaptopurine and 8-azaguanine. J Org Chem 26:1926–1929
Morr M (1976) Synthese des 5′-thio-3′-amido-5′,3′-didesoxyadenosin-3′,5′-cyclophosphats, ein cAMP-derivat mit s und N im Cyclophosphatring. Tetrahedron Lett 2127–2128
Morr M, Ernst L (1978) Zur Reaktion von Aminonucleosiden mit Thiophosphorylierungs-reagenzien. Chem Ber 111:2152–2172
Morr M, Kula M-R, Ernst L (1975) Synthesis and 13C NMR spectra of 3′-amido analogs of adenosine 3′,5′-cyclic monophosphate. Tetrahedron 31:1619–1622
Morr M, Kula M-R, Roesler G, Jastorff B (1974) Synthesis of 3′-amido-3′-deoxyadenosine 3′,5′-cyclophosphate. Angew Chem (Engl) 13:280–281
Morr M, Mengel R (1977) Synthese der cycloamide der xylo-3′-amino-3′-desoxyadenosin-5′-phosphorsäure und-5′-thionophosphorsäure, zweier neuer cAMP-analoga. Chem Ber 110:3947–3949
Moss J, Vaughan M (1979) Activation of adenylate cyclase by choleragen. Ann Rev Biochem 48:581–600
Mukaiyama T, Hashimoto M (1972) Synthesis of oligothymidylates and nucleoside cyclic phosphates by oxidation-reduction condensation. J Am Chem Soc 94:8528–8532
Muneyama K, Bauer RJ, Shuman DA, Robins RK, Simon LN (1971) Chemical synthesis and biological activity of 8-substituted adenosine 3′,5′-cyclic monophosphate derivatives. Biochemistry 10:2390–2395
Muneyama K, Shuman DA, Boswell KH, Robins RK, Simon LN, Miller JP (1974) Synthesis and biological activity of 8-haloadenosine 3′,5′-cyclic phosphates. J Carbohydr Nucleosides Nucleotides 1:55–60
Murad F (1973) Clinical studies and applications of cyclic nucleotides. Adv Cyclic Nucleotide Res 3:355–383
Murad F, Rall TW, Vaughan M (1969) Conditions for the formation, partial purification and assay of an inhibor of adenosine 3′,5′-monophosphate. Biochim Biophys Acta 192:430–445
Murayama A, Jastorff B, Cramer F, Hettler H (1971) 5′-Amido analogs of adenosine 3′,5′-cyclic monophosphate. J Org Chem 36:2029–3033
Murayama A, Jastorff B, Hettler H (1970) Synthesis of 5′-amido analogs of adenosine (3′–5′)-cyclophosphates. Angew Chem (Engl) 9:640–641
Murayama A, Jastorff B, Hettler H, Cramer F (1973) Die Stereoselektivität bei der Synthese von 5′-N-substituierten 5′-amido-analoga des Adenosin-3′,5′-cyclophosphat-p-nitro-phenylesters. Chem Ber 106:3127–3131
Mushika Y, Taguchi Y (1976) Cyclic nucleotides. Japan Kokai 76 65,773
Nagyvary J (1969) Arabinonucleotides IL The synthesis of O2, 2′-anhydrocytidine 3′-phosphate, a precursor of 1-β-D-arabinosylcytosine. J Am Chem Soc 91:5409–5410
Nagyvary J, Gohil RN, Kirchner CR, Stevens JD (1973) Studies on neutral esters of cyclic AMP. Biochem Biophys Res Commun 55:1072–1077
Nair KG (1966) Purification and properties of 3′,5′-cyclic nucleotide Phosphodiesterase from dog heart. Biochemistry 5:150–157
Naito T, Sano M (1965) Adenosine cyclic 3′,5′-phosphate. Japanese Patent 9,063
Naka T, Honjo M (1976 a) Synthesis of 8-carbamoyl-and 8-carboxyadenosine 3′,5′-cyclic phosphates. Chem Pharm Bull (Tokyo) 24:2052–2056
Naka T, Honjo M (1976 b) 8-Substituted adenosine-3′,5′-cyclic phosphates. Japan Kokai 76 04,195
Nathanson JA, Greengard P (1977) Second messengers in the brain. Sci Am 237:108–119
Nawrath H (1977) Does cyclic GMP mediate the negative inotropic effect of acetylcholine in the heart? Nature 267:72–74
Nawrath H (1978) Rec Adv Stud Card Struct Metab 11:419
Nayler WG (1977) Cyclic nucleotides and the heart. Adv. Drug Res 12:39–51
Naylor R, Gilham PT (1966) Studies on some interactions and reactions of oligonucleotides in aqueous solution. Biochemistry 5:2722–2728
Nedorezova TP, Melnik SYa, Yartseva IV, Preobrazhenskaya MN (1978) (R)-and (S)-2′,3′-O-adamantylphosphonates of purine nucleosides. Bioorg Khim (USSR) 4:1058–1064
Niles RM, Ludwig KW, Makarski JS (1979) Differential growth inhibition in two human carcinoma cell lines by cyclic adenosine 5′-monophosphate analogs. J Natl Cancer Inst 63:909–911
Niles RM, Makarski JS, Kurtz MJ, Rutenburg AM (1976) Inhibition of human prostatic epithelial cell replication by cAMP and selcted analogs. Exp Cell Res 102:95–103
Nohara A, Imai K, Honjo M (1966) Synthesis of the glucose analogs of inosine-5′ phosphate. Chem Pharm Bull (Tokyo) 14:491–495
Nutt RF, Walton E (1968) Branched-chain sugar nucleosides. IL 5′,5′-Di-C-methyl-adenosine. J Med Chem 11:151–153
Oey J, Vogel A, Pollack R (1974) Intracellular cyclic AMP concentration responds specifically to growth regulation by serum. Proc Natl Acad Sci USA 71:694–698
Okruszek A, Verkade JG (1979) 2′,3′-Bis(2-chloroethyl)aminophosphoryl-3′-amino-3′-deoxyadenosine: A cyclic nucleotide with antitumor activity. J Med Chem 22:882–885
O’Neill JP, Schröder CH, Hsie AW (1975) Hydrolysis of butyryl derivatives of adenosine cyclic 3′,5′-monophosphate by Chinese hamster ovary cell extracts and characterization of the products. J Biol Chem 250:990–995
Ortiz PJ (1972) The inhibition of E. coli adenyl cyclase by ara ATP. Biochem Biophys Res Commun 46:1728–1733
Owens JR, Haley BE (1978) Use of photoaffinity nucleotide analogs to determine the mechanism of ATP regulation of a membrane-bound, cAMP-activated protein kinase. J Supramol Str 9:57–68
Panitz N, Reike E, Morr M, Wagner KG, Roesler G, Jastorff B (1975) The 3′-amido and 5′-amido analogues of adenosine 3′,5′-monophosphate; Interaction with cAMP-specific proteins. Eur J Biochem 55:415–422
Panzica RP, Rousseau RJ, Robins RK, Townsend LB (1972) A study on the relative stability and a quantitative approach to the reaction mechanism of the acid-catalyzed hydrolysis of certain 7-and 9-β-D-ribofuranosylpurines. J Am Chem Soc 94:4708–4714
Paoletti R, Berti F, Spano PF (1973) Cyclophosphates. V. In vivo metabolic and cardiovascular effects of new cyclophosphates. Pharmacol Res Commun 5:87–100
Pardee AB, de Asua LJ, Rozengurt E (1974) In: Clarkson B, Baserga R (eds) Control of Proliferation of Animal Cells, vol 1. Cold Spring Harbor Conferences on Cell Proliferation, p 547
Pastan IH, Johnson GS, Anderson WB (1975) Role of cyclic nucleotides in growth control. Ann Rev Biochem 44:491–522
Pike JE, Slechta L, Wiley PF (1964) Tubercidin and related compounds. J Heterocycl Chem 1:159–161
Pischel H, Holý A (1970) Oligonucleotid-verbindungen XXXVII. Synthese einiger nucleotid-derivate von 1-(β-D-ribofuranosyl)pyrimidon-(2) und 3-(β-D-ribofuranosyl)pyrimidon-(4). Coll Czech Chem Commun 35:3584–3596
Pizer FL, Ballou CE (1959) Studies on myo-inositol phosphates of natural origin. J Am Chem Soc 81:915–921
Pogson CI (1974) Guanine nucleotides and their significance in biochemical processes. Am J Clin Nutr 27:380–402
Polgar P, Vera JC, Kelley PR, Rutenburg AM (1973) Adenylate cyclase activity in normal and leukemic human leukocytes as determined by a radioimmunoassay for cyclic AMP. Biochim Biophys Acta 297:378–383
Porter KR, Puck TT, Hsie AW, Kelley D (1974) An electron microscope study of the effects of dibutyryl cyclic AMP on Chinese hamster ovary cells. Cell 2:145–162
Posternak T (1971) Chemistry of cyclic nucleoside phosphates and synthesis of analogs. In: Robison, Butcher, Sutherland (eds) Cyclic AMP. Academic Press, New York, pp 48–71
Posternak T (1974) Cyclic AMP and Cyclic GMP. Annu Rev Pharmacol 14:23–33
Posternak T, Falbriard JG (1971) Preparation of cyclic GMP. In: Robison, Butcher, Sutherland (eds) Cyclic AMP. Academic Press, New York
Posternak T, Marcus I, Cehovic G (1971) Préparation de nouveaux dérivés de l’AMPs (substitués en position C-8 et C-2) et étude de leur action sur la libération de l’hormone de croissance. CR Acad Sci Paris 272D:622–625
Posternak T, Marcus I, Gabbai A, Cehovic G (1969) Préparation et étude de quelques properiétés biologiques d’analogues de l’acide adénosine-3′,5′-phosphorique. CR Acad Sci Paris 269D:2409–2412
Posternak T, Sutherland EW, Henion WF (1962) Derivatives of cyclic 3′,5′-adenosine monophosphate. Biochim Biophys Acta 65:558–560
Prasad KN, Sheppard JR (1972) Inhibitors of cyclic-nucleotide Phosphodiesterase induce morphological differentiation of mouse neuroblastoma cell culture. Exp Cell Res 73:436–440
Preobrazhenskaya NN, Shabarova ZA, Prokofev MA (1967) The synthesis and hydrolytic stability of amino acid derivatives of uridine cyclophosphates. Dokl Akad Nauk SSSR 174:100–103
Price TD, Ashman DF, Melicow MM (1967) Organophosphate of urine, including adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate. Biochim Biophys Acta 138:452–465
Prystäs M, Šorm F (1969) Nucleic acid components and their analogues. CXXVII. Synthesis of uridine and cytidine 6-methyl and 5,6-dimethyl derivatives. Coll Czech Chem Commun 34:2316–2347
Puck TT (1977) Cyclic AMP, the microtubule-microfilament system, and cancer. Proc Natl Acad Sci USA 74: 4491–4495
Puck TT (1979) Studies on cell transformation. Somatic Cell Genet 5:973–990
Pullman B, Saran A (1976) Quantum-mechanical studies on the conformation of nucleic acids and their constituents. Progr Nucleic Acid Res Mol Biol 18:215–325
Rall TW, Sutherland EW (1958) Formation of a cyclic adenine ribonucleotide by tissue particles. J Biol Chem 232:1065–1076
Rall TW, Sutherland EW, Berthet J (1957) The relationship of epinephrine and glucagon to liver Phosphorylase. IV. Effect of epinephrine and glucagon on the reaction of phosphorylase in liver homogenates. J Biol Chem 224:463–475
Ramseyer J, Kaslow HR, Gill GN (1974) Purification of the cAMP receptor protein by affinity chromatography. Biochem Biophys Res Commun 59:813–821
Ranganathan RS, Jones GH, Moffatt JG (1974) Novel Analogs of nucleoside 3′,5′-cyclic phosphates. I. 5′-Mono-and dimethyl analogs of adenosine 3′,5′-cyclic phosphate. J Org Chem 39:290–298
Reddi PK, Constantinides SM (1972) Partial suppression of tumor production by dibutyryl cyclic AMP and theophylline. Nature 238:286–287
Reddy BS, Viswamitra MA (1971) Crystal data of an ammonium salt of cyclic cytidine-2′,3′-phosphate. Current Sci 40:625
Revankar GR, Huffman JH, Allen LB, Sidwell RW, Robins RK, Tolman RL (1975) Synthesis and antiviral activity of certain 5′-monophosphates of 9-D-arabinofuranosyl-adenine and 9-D-arabinofuranosylhypoxanthine. J Med Chem 18:721–726
Revankar GR, Huffman JH, Sidwell RW, Tolman RL, Robins RK, Allen LB (1976) Synthesis and anti-DNA virus activity of the 5′-monophosphate and the cyclic 3′,5′-mono-phosphate of 9-(β-D-xylofuranosyl)guanine. J Med Chem 19:1026–1028
Robbins SJ, Rapp F (1979) Abstracts Mtgs Chem Soc for Microbiology, p 261, Abstract S130, Los Angeles
Robins MJ, MacCoss M (1977) Nucleic acid related compounds. 26. A “geometry-only” method for determining the anomeric configuration of nucleosides based on the H-1′ NMR signal of cyclic α and β 3′,5′-mononucleotides. J Am Chem Soc 99:4654–4660
Robins MJ, MacCoss M, Wilson JS (1977) nucleic acid related compounds. 27. “Virtual Coupling” of the anomeric proton of cyclic 2′-deoxynucleoside 3′,5′-monophosphates. Reassessment of conformation using praseodymium shifts and assignment of H-2′,2″ signals by biomimetic deuteration at C-2. J Am Chem Soc 99:4660–4666
Robins RK (1979) The synthesis and structure activity relationship of analogues and derivatives of 3′,5′-cyclic nucleotides. In: Simkin (ed) Proc 6 th Internati Sym Med Chem, Brighton, UK. Cotswold Press Ltd, Oxford, UK, pp 127–135
Robins RK, Khwaja TA (1974) 3′,5′-Cyclic monophosphate nucleosides. US Patent 3,849,397
Robins RK, Shuman DA, Boswell KH (1977 a) 6-Aminocarbonyl purine 3′,5′-cyclic nucleotides. US Patent 4,038,480
Robins RK, Shuman DA, Boswell KH (1977b) 6,8-Disubstituted purine derivatives of 9-β-D-ribofuranosyl 3′,5′-cyclic phosphate. US Patent 4,058,659
Robison GA (1970) Cyclic AMP as a second messenger. J Reprod Fert Suppl 10:55–74
Robison GA (1972) Cyclic AMP and hormone action. Am J Pharm Educ 36:723–733
Robison GA (1975) Cyclic AMP and disease: An overview. In: Good, Day, Yums (eds) Molecular pathology. CC Thomas Publ, Springfield, Ill, pp 394–404
Robison GA, Arnold A, Hartmann RC (1969) Divergent effects of epinephrine and prostaglandin E1 on the level of cyclic AMP in human blood platelets. Pharm Res Commun 1:325–332
Robison GA, Butcher RW, Sutherland EW (1968) Cyclic AMP. Annu Rev Biochem 37:149–174
Robison GA, Butcher RW, Sutherland EW (1971 a) Cyclic AMP. Academic Press, New York
Robison GA, Nahas GG, Triner L (1971 b) Cyclic AMP and cell function. Ann NY Acad Sci 185:5–556
Robison GA, Park CR (1970) Cyclic adenylate in mammalian tissues. In: Ellenberg, Rifkin (eds) Diabetes mellitus: Theory and practise. McGraw-Hill, New York, pp 132–149
Robison GA, Sutherland EW (1967) Adenylic acid (cyclic). McGraw Hill Yearbook of Science and Technology, New York, pp 91–92
Robison GA, Sutherland EW (1971) On the relation of cyclic AMP to adrenergic receptors and sympathin. Adv Cytopharmacol 1:263–272
Rosario EJ del, Hammes GG (1970) Relaxation spectra of ribonuclease. VII. The interaction of ribonuclease with uridine 2′,3′-cyclic phosphate. J Am Chem Soc 92:1750–1753
Rosen OM (1970) Interaction of cyclic GMP and cyclic AMP with a cyclic nucleotide phosphodiesterase of the frog erythrocyte. Arch Biochem Biophys 139:447–449
Rosett T, Smith JG Jr, Matsuo I, Bailey PA, Smith DB, Surakiat S (1970) The quantitative separation of 3′,5′-cyclic adenosine monophosphate, adenosine-5′-monophosphate, adenosine-5′-diphosphate, and adenosine-5′-triphosphate by ion-exchange chromatography on diethylaminoethyl sephadex. J Chromatogr 49:308–312
Rosowsky A, Gohil RN (1978) 6-Amino-9-β-D-arabinofuranosylpurine-8-thiol 3′,5′-cyclic phosphate. Nucleic Acid Chem, Improved and New Synthetic Procedures, Methods, and Techniques, Townsend and Tipson (eds) pt 2. John Wiley and Sons, New York, pp 857–860
Rubin CS, Rosen OM (1975) Protein phosphorylation. Ann Rev Biochem 44:831–887
Rudland PS, Seeley M, Seifert W (1974) Cyclic GMP and cyclic AMP levels in normal and transformed fibroblasts. Nature 251:417–419
Rudolph SA, Johnson EM, Greengard P (1971) The enthalpy of hydrolysis of various 3′,5′-and 2′,3′-cyclic nucleotides. J Biol Chem 246:1271–1273
Russell AF, Moffatt JG (1969) Synthesis of some nucleotides derived from 3′-deoxythy-midine. Biochemistry 8:4889–4896
Saenger W, Eckstein F (1969) Crystal structure of uridine 2′,3′-O,O-cyclophosphorothioate. Angew Chem (Engl) 8:595–596
Saenger W, Eckstein F (1970) Stereochemistry of a substrate for pancreatic ribonuclease. Crystal and molecular structure of the triethylammonium salt of uridine 2′,3′-O,O-cyclophosphorothioate. J Am Chem Soc 92;4712–4718
Sands H, Rickenberg HV (1978) Assessment of the role of cyclic nucleotides as hormonal mediators. In: Rickenberg HV (ed) Int rev biochim: Biochemistry and mode of action of hormones II, vol 20, University Park Press, Baltimore, Maryland, pp 45–80
Saran A, Berthod H, Pullman B (1973) Molecular orbital calculations on the conformation of nucleic acids and their constituents. VIII. Conformations of 2′,3′-and 3′,5′-cyclic nucleotides. Biochim Biophys Acta 331:154–164
Sasaki Y, Kodaira R, Nozawa R, Yokota T (1978) Inhibitory effect of 8-substituted adenosine derivatives on Ca++ and modulator protein-dependent Phosphodiesterase activity. Biochem Biophys Res Commun 84:277–284
Sasaki Y, Suzuki N, Sowa T, Nozawa R, Yokota T (1976) Effects of 8-substituted adenosine 3′,5′-monophosphate derivatives on high Km phosphodiesterase activity. Biochemistry 15:1408–1413
Sasisekharan V, Lakshminarayanan AV, Ramachandran GN (1967) In: Ramachandran (ed) Conformation of biopolymers. Academic Press, New York, pp 641–654
Schaeffer HJ, Thomas HJ (1958) Synthesis of potential anticancer agents. XIV. Ribosides of 2,6-disubstituted purines. J Am Chem Soc 80:3738–3742
Scheit KH (1974) Biological and spectroscopic properties of a fluorescent cyclic AMP analogue, 2-aminopurine nucleoside-5′.3′-cyclic phosphate. J Carbohydr Nucleosides Nucleotides 1:385–399
Schmidt MJ, Truex LL, Leonard NJ, Scopes DI, Barrio JR (1978) Effect of lin-ben-zoadenosine and lin-benzoadenosine 3′,5′-monophosphate on cyclic AMP-dependent protein kinase activity in vitro. J Cyclic Nucleotide Res 4:201–207
Schweizer MP, Broom AD, Ts’o POP, Hollis DP (1968) Studies of inter-and intramolecular interaction in mononucleotides by proton magnetic resonance. J Am Chem Soc 90:1042–1055
Schweizer MP, Robins RK (1973) NMR studies on the conformation of nucleosides and 3′,5′-cyclic nucleotides. Conformation of Biological molecules and polymers. In: Pullman, Bergmann (eds) Proceedings of the Fifth Jerusalem Symposium on Quantum Chemistry and Biochemistry. Academic Press, New York, pp 329–343
Scopes DIC, Barrio JR, Leonard NJ (1977) Defined dimensional changes in enzyme cofactors: Fluorescent “stretched-out” analogs of adenine nucleotides. Science 195:296–298
Secrist III JA (1974) The synthesis of 1,N6-ethenoadenosine 3′,5′-monophosphate; A fluorescent analog of cyclic AMP. Methods Enzymol 38c:428–430
Secrist III JA, Barrio JR, Leonard NJ, Palasi CV, Gilman AG (1972 a) Fluorescent modification of adenosine 3′,5′-monophosphate: Spectroscopic properties and activity in enzyme systems. Science 177:279–280
Secrist III JA, Barrio JR, Leonard NJ (1972 b) A fluorescent modification of adenosine triphosphate with activity in enzyme systems: 1,N6-Ethenoadenosine triphosphate. Science 175:646–647
Seifert WE, Rudland PS (1974) Possible involvement of cyclic GMP in growth control of cultured mouse cells. Nature 248:138–140
Severin ES, Gulyaev NN, Bulargina TV, Kochetkova MN (1979 a) Specific inhibition of cyclic AMP-dependent protein kinase, adenylate cyclase and phosphodiesterase by ATP and cyclic AMP analogs. In: Weber G (ed) Adv. Enzyme Regulation, vol 17. Pergamon Press, New York, p251
Severin ES, Nesterova MV, Sashchenko LP, Rasumova VV, Tunitskaya VL, Kochetkov SN, Gulyaev NN (1975) Investigation of the adenosine 3′,5′-cyclic phosphate binding site of pig brain histone kinase with the aid of some analogues of adenosine 3′,5′-cyclic phosphate. Biochim Biophys Acta 384:413–422
Severin ES, Sashchenko LP, Kochetkov SN, Gulyaev NN, Kurochkin SN, Trakht IN (1979 b) Structure and mechanism of action of cyclic AMP-dependent protein kinase. In: Krause EG, Pinna L, Wollenberger A (eds) FEBS 12 th Meeting, Dresden 1978, vol 54. Symposium 7, Cyclic Nucleotides and Protein Phosphorylation in Cell Regulation. Pergamon Press, London, p 101
Severin ES, Tkachuk VA, Gulyaev NN (1976) Interaction of adenosine-3′,5′-cyclosulfate with adenosine-3′,5′-cyclophosphate-dependent protein kinase and phosphodiesterase. Biokhimiya 41:384–388
Shahak Y, Chipman DM, Shavit N (1973) Photophosphorylation studies with fluorescent adenine nucleotide analogs. FEBS Lett 33:293–296
Shapiro R, Danzig M (1972) Acidic hydrolysis of deoxycytidine and deoxyuridine derivatives. The general mechanism of deoxyribonucleoside hydrolysis. Biochemistry 11:23–29
Shields R (1974) In: Dumont JE, Brown BL, Marshall NJ (eds) Eukaryotic cell function and growth. Plenum Press, London, p 747
Sheldrick WS, Reike E (1978) 8-[(2-Aminoethyl)amino]adenosine cyclic 3′,5′-monophosphate tetrahydrate. Acta Cryst 34B:2324–2327
Shen TY (1970) Nucleosides and nucleotides as potential therapeutic agents. Angew Chem (Engl) 9:678–688
Shibuya M, Arai K, Kaziro Y (1975) A novel method for the determination of guanosine 3′,5′-cyclic monophosphate (cyclic GMP). Biochem Biophys Res Commun 62:129–135
Shin S, Freedman VH, Risser R, Pollack R (1975) Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc Natl Acad Sci USA 72:4435–4439
Shiue C-Y, Chu S-H (1975) A convenient one-step synthesis of 6-selenoxo-9-(β-D-ribo-furanosyl)purine 3′,5′-cyclic phosphate and related compounds. J Heterocycl Chem 12:493–500
Shugar D, Wierzchowski KL (1958) Preparation of nucleoside 3′,5′-cyclic phosphates and some ribonucleotide isomers. Bull Acad Polon Sci, Ser Sci Biol 6:283
Shuman DA, Meyer RB Jr (1975) 6-Substituted purine nucleotides. US Patent 3,915,958
Shuman DA, Meyer RB Jr, Robins RK (1975) 2,6-Disubstituted purine cyclic nucleotides. US Patent 3,897,413
Shuman DA, Meyer RB Jr, Robins RK (1976) 6-Substituted purine 3′,5′-cyclic nucleotides. US Patent 3,948,886
Shuman DA, Miller JP, Scholten MB, Simon LN, Robins RK (1973) Synthesis and biological activity of some purine 5′-thio-5′-deoxynucleoside 3′,5′-cyclic phosphorothioates. Biochemistry 12:2781–2786
Shuman DA, Robins RK (1974a) 2′-O-Methyladenosine 3′,5′-cyclic phosphate. US Patent 3,816,400
Shuman DA, Robins RK (1974 b) Nucleoside 3′,5′-cyclic phosphorothioates. US Patent 3,853,844
Sidwell RW, Huffman JH, Allen LB, Meyer RB Jr, Shuman DA, Simon LN, Robins RK (1974) In vitro antiviral activity of 6-substituted 9-β-D-ribofuranosylpurine 3′,5′-cyclic phosphates. Antimicrob Agents Chemother 5:652–657
Sidwell R, Huffman J, Shuman D, Muneyama K, Robins R (1972) Cyclic AMP derivatives as antiviral agents. Proceedings of the VIIth Int Cong of Chemotherapy, Prague, 1971, pp 313–314
Sidwell RW, Simon LN, Huffman JH, Allen LB, Long RA, Robins RK (1973) DNA virus inhibitory activity of 1-β-D-arabinofuranosylcytosine-3′,5′-cyclic phosphate. Nature New Biol 242:204–206
Siggins GR, Henriksen SJ (1975) Analogs of cyclic adenosine monophosphate: Correlation of inhibition of purkinje neurons with protein kinase activation. Science 189:559–560
Simon LN, Shuman DA, Robins RK (1973) The chemistry and biological properties of nucleotides related to nucleoside 3′,5′-cyclic phosphates. Adv Cyclic Nucleotide Res 3:225–353
Smith ICP, Mantsch HH, Lapper RD, Deslauriers R, Schleich T (1973) A study of the conformations of nucleic acids by carbon-13 and hydrogen nuclear magnetic resonance spectroscopy. In: Pullman, Bergman (ed) 5th Jerusalem Symposium on Quantum Chem Biochem. Academic Press, New York, pp 381–401
Smith M (1964) Synthesis of deoxyribonucleoside-3′,5′-cyclic phosphates by base-catalysed transesterification. J Am Chem Soc 86:3586
Smith M, Drummond GI, Khorana HG (1961) Cyclic phosphates. IV. Ribonucleoside-3′,5′-cyclic phosphates. A general method of synthesis and some properties. J Am Chem Soc 83:698–706
Smith M, Jardetzky CD (1968) The NMR spectra and conformation of the nucleotide 3′,5′-cyclic phosphates. J Mol Spectroscopy 28:70–80
Smith M, Khorana HG (1959) Specific synthesis of the C5-C3′ interribonucleotide linkage: The synthesis of uridylyl-(5′→3′)-uridine. J Am Chem Soc 81:2911–2912
Smith M, Moffatt JG, Khorana HG (1958) Carbodiimides. VIII. Observations on the reactions of carbodiimides with acids and some new applications in the synthesis of phosphoric acid esters. J Am Chem Soc 80:6204–6212
Smith SW, Werthamer S, Artman M (1974) Differential effects of dibutyryl cyclic AMP on the growth and morphology of an established human lymphocyte line. In Vitro 10:225–229
Smrt J (1967) Oligonucleotidic compounds. XVI. Synthesis of 5,6-dihydrouridine analogues of guanylyl-(3′→5′)-uridylyl-(3′→5′)-uridine. Coll Czech Chem Commun 32:198–205
Smrt J (1974) A remark on the preparation of protected guanosine 3′-phosphate by means of a mixture of ribonucleases T1 and T2. Coll Czech Chem Commun 39:969–971
Sowa T, Suzuki N, Sasaki Y, Yokota T (1976) Cyclic adenosine monophosphate derivative. Japan Kokai 76 41,388
Stadel JM, Goodman DBP (1978) 8-p-Chlorophenylthio-cyclic AMP: A potent partial simulator of antidiuretic hormone action. J Cyclic Nucleotide Res 4:35–43
Stanwick TL, Nahmias AJ (1979) Abstracts, Mtgs Am Soc for Microbiology, p 290, Abstract No. S306 Los Angeles
Steiner AL, Ferrendelli JA, Kipnis DM (1972 c) Radio-immunoassay for cyclic nucleotides. III: Effects of ischemia, changes during development and regional distribution of adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in mouse brain. J Biol Chem 247:1121–1124
Steiner AL, Pagliara AS, Chase LR, Kipnis DM (1972 b) Radioimmunoassay of cyclic nucleotides. IL Adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in mammalian tissues and body fluids. J Biol Chem 247:1114–1120
Steiner AL, Parker CW, Kipnis DM (1972 a) Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem 247:1106–1113
Steiner AL, Kipnis DM, Utiger R, Parker C (1969) Radioimmunoassay for the measurement of adenosine 3′,5′-cyclic phosphate. Proc Natl Acad Sci USA 64:367–373
Steiner RF (1972) The activity of ε-adenosine derivatives as allosteric modifiers of phosphorylase b. FEBS Lett 23:139–141
Steitz TA, Lipscomp WN (1965) Molecular structure of methyl ethylene phosphate. J Am Chem Soc 87:2488–2489
Stevens RH, Smith DD, Osborne JW, Oberley LW (1976) Adenosine 3′,5′-cyclic monophosphate levels in x-ray-induced small-bowel adenocarcinoma in the rat. J Natl Cancer Inst 57:43–45
Straus DB, Fresco JR (1965) Synthesis of N-benzoyl-2′-O-tetrahydropyranylguanosine-phosphate, an intermediate in the chemical synthesis of polyriboguanylic acid. J Am Chem Soc 87:1364–1374
Su J-C, Hassid WZ (1962) Carbohydrates and nucleotides in the red alga Porphyra perforate. II. Separation and identification of nucleotides. Biochemistry 1:474–480
Suehiro H, Kikugawa K, Ichino M, Nakamura T (1976) 2-Substituted thioadenosine-5′-monophosphates. Japan Kokai 76 76,291
Sundaralingam M (1975) Structure and conformation of nucleosides and nucleotides and their analogs as determined by x-ray diffraction. Ann NY Acad Sci 255:3–42
Sundaralingam M, Abola J (1972 a) Molecular conformation of adenosine 3′,5′-monophosphate monohydrate. Nature New Biol 235:244–245
Sundaralingam M, Abola J (1972 b) Stereochemistry of nucleic acids and their constituents. XXVII. The crystal structure of 5′-methyleneadenosine 3′,5′-cyclic monophosphonate monohydrate, a biologically active analog of the secondary hormonal messenger cyclic adenosine 3′,5′-monophosphate. Conformational “rigidity” of the furanose ring in cyclic nucleotides. J Am Chem Soc 94:5070–5076
Sutherland EW, Rall TW (1957) The properties of an adenine ribonucleotide produced with cellular particles, ATP, Mg++, and epinephrine or glucagon. J Am Chem Soc 79:3608
Sutherland EW, Rall TW (1958) Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles. J Biol Chem 232:1077–1091
Sutherland EW, Robison GA (1966) Metabolic effects of catecholamines. A. The role of cyclic-3′,5′-AMP in responses to catecholamines and other hormones. Pharmacol Rev 18:145–161
Sutherland EW, Robison GA, Butcher RW (1968) Some aspects of the biological role of adenosine 3′,5′-monophosphate (cyclic AMP). Circulation 37:279–306
Suzaki S, Yamazaki A, Kamimura A, Mitsugi K, Kumashiro I (1970) Synthesis of 9-β-D-xylofuranosyl-6-mercaptopurine and 9-β-D-xylofuranosylguanine 5′-phosphate. Chem Pharm Bull (Tokyo) 18:172–176
Suzuki T, Kambayashi M, Matsuishi N (1972) 2′,3′-Dibutyrylriboflavin cyclic-4′,5′-phosphate. Japan Patent 72 08,316
Swislocki NI (1970) Decomposition of dibutyryl cyclic AMP in aqueous buffers. Anal Biochem 38:260–269
Symons RH (1970) 32P-3′,5′-cyclic AMP: A simple preparative procedure. Biochem Biophys Res Commun 38:807–870
Symons RH (1973) Improved synthesis of 32P-labelled 3′,5′-cyclic AMP, 3′,5′-cyclic GMP and other 3′,5′-cyclic ribo-and deoxyribonucleotides of high specific activity. Biochim Biophys Acta 320:535–539
Symons RH (1974) The synthesis of [32P]adenosine 3′,5′-cyclic phosphate and other ribo-and deoxyribonucleoside 3′,5′-cyclic phosphates. Methods Enzymol 38:410–420
Szabó P, Szabó L (1958) Alkaline hydrolysis of methyl α-D-glucoside 4,6-phosphate. Compt Rend 247:1748–1750
Szaduykis-Szadurski Berti F (1972) Smooth muscle relaxing activity of 8-bromoguanosine-3′,5′-monophosphate. Pharmacol Res Commun 4:53–61
Szer W, Shugar D (1963) Ribonucleoside 2′,3′-cyclic phosphates. Biochem Prep 10:139–144
Taguchi Y, Mushika Y (1975) Synthetic studies on phosphorylating reagents. IV. A novel synthesis of nucleoside-3′,5′-cyclic phosphates by the use of 2-(N,N-dimethylamino)-4-nitrophenyl phosphate. Bull Chem Soc (Japan) 48:1528–1532
Taguchi Y, Sishimura N, Kakimoto T, Mushika Y (1976) Synthetic studies on phosphorylating reagents. V. A convenient synthesis of 2′,3′-cyclic coenzyme A. Bull Chem Soc (Japan) 49:1122–1125
Takaku H, Kato M, Hata T (1978) Preparation of nucleoside 3′,5′-cyclic phosphates via 8-quinolyl nucleoside 5′-phosphates as a useful intermediate. Chemistry Lett 181–184
Tanaka K (1960) A simple preparative method for ribonucleoside-2′,3′-cyclic phosphates. J Biochem (Tokyo) 47:398–399
Tazawa I, Tazawa S, Alderfer JL, Ts’o POP (1972) A novel procedure for the synthesis of 2′-O-alkyl nucleotides. Biochemistry 11:4931–4937
Tener GM, Khorana HG (1955) Cyclic Phosphates. II. Further studies of ribonucleoside 2′,3′-cyclic phosphates. J Am Chem Soc 77:5349–5351
Tener GM, Khorana HG, Markham R, Pol EH (1958) Studies on polynucleotides. II. The synthesis and characterization of linear and cyclic thymidine oligonucleotides. J Am Chem Soc 80:6223–6230
Tesser GI, Fisch H, Schwyzer R (1972) Limitations of affinity chromatography: Sepharosebound cyclic 3′,5′-adenosine monophosphate. FEBS Lett 23:56–58
Tewari R, Danyluk SS (1978) Configurational effects on conformational properties of cyclic nucleotides. I. Theoretical calculations of conformer preferences in α-nucleoside 3′,5′-cyclic monophosphates. Biopolymers 17:1181–1196
Thomas HJ, Hewson K, Montgomery JA (1962) The 2′(3′)-phosphates of 6-mercaptopurine ribonucleoside and 8-azaguanosine. J Org Chem 27:192–194
Thomas HJ, Montgomery JA (1968) Derivatives and analogs of 6-mercaptopurine ribonucleotide. J Med Chem 11:44–48
Tikhomirova-Sidorova NS, Kogan ÉM, Sysoev VA, Ustyuzhanin GE (1971) Alcoholysis of pyrimidine nucleoside 2′,3′-cyclophosphates with purine nucleosides in frozen solutions in presence of pancreatic ribonuclease. Zh Obshch Khim 41:2570–2575
Tikhomirova-Sidorova NS, Kogan ÉM, Ustyuzhanin GE (1973) Synthesis of pyrimidine oligonucleotides in frozen solutions in presence of pancreatic ribonuclease. Zh Obshch Khim 43:393–399
Tisdale MJ (1979) The significance of cyclic AMP and cyclic GMP in cancer treatment. Cancer Tratment Rev 6:1–15
Tisdale MJ, Phillips BJ (1974) Apparent correlation between adenosine 3′,5′-cyclic monophosphate levels and malignancy in somatic cell hybrids. Exp Cell Res 88:111–120
Tovey MG, Rochette-Egly C, Castagna M (1979) Effect of interferon on concentration of cyclic nucleotides in cultured cells. Proc Natl Acad Sci USA 76:3890–3893
Tsien RW (1977) Cyclic AMP and contractile activity in heart. Adv Cyclic Nucleotide Res 8:363–420
Ts’o POP (1974) Bases, nucleosides, and nucleotides. In: Ts’o POP (ed) Basic principles in nucleic acid chemistry, vol 1. Academic Press, Inc, New York, pp 453–584
Ts’o POP, Kondo NS, Schweizer MP, Hollis DP (1969) Studies of the conformation and interaction in dinucleoside mono-and diphosphates by proton magnetic resonance. Biochemistry 8:997–1029
Tsou KC, Yip KF, Miller EE, Lo KW (1974) Synthesis of 1,N6-etheno-2-aza-adenosine (2-aza-ε-adenosine): a new cytotoxic fluorescent nucleoside. Nucleic Acids Res 1:531–547
Tunitskaya VL, Gulyaev NN, Poletaev AI, Severin ES (1977) Study of conformation of cyclic adenosine-3′,5′-monophosphate and some of its derivatives by the method of circular dichroism. Biokhimiya 42:746–753
Turner AF, Khorana HG (1959) Studies on polynucleotides. VI. Experiments on the chemical polymerization of mononucleotides. Oligonucleotides derived from thymidine-3′ phosphate. J Am Chem Soc 81:4651–4656
Ueda T, Fox JJ (1967) The mononucleotides. In: Wolfrom, Tipson (eds) Advances in carbohydrate chemistry, vol 22. Academic Press, New York, pp 307–419
Ueda T, Imazawa M, Miura K, Iwata R, Odajima K (1971) A facile conversion of amino to thiono group in certain nucleobases. Tetrahedron Lett 2507–2510
Ueda T, Kawai I (1970) A convenient synthesis of ribonucleoside 2′,3′-cyclic phosphates from ribonucleosides and ribonucleotides. Chem Pharm Bull (Tokyo) 18:2303–2308
Uesugi S, Tanaka S, Ikehara M (1979) Carbon-13 NMR spectra of nucleoside 3′,5′-cyclic phosphates. Proposition for revised signal assignments. Org Magnetic Resonance 12:143–145
Ukita T, Hayatsu H (1961) Organic phosphates. XVIII. Synthesis of lyxouridine 2′,3′-cyclic phosphate and related compounds. Chem Pharm Bull (Tokyo) 9:1000–1005
Uno H, Meyer RB Jr, Shuman DA, Robins RK, Simon LN, Miller JP (1976) Synthesis of some 1,8-and 2,8-disubstituted derivatives of adenosine cyclic 3′,5′-phosphate and their interaction with some enzymes of cAMP metabolism. J Med Chem 19:419–422
Usher DA, Dennis EA, Westheimer FH (1965) Calculation of the bond angles and conformation of methyl ethylene phosphate and related compounds. J Am Chem Soc 87:2320–2321
van Boom JH, Burgers PM, Deursen P (1974) Preparation of nucleoside 3′,5′-cyclic phosphates via phosphotriester intermediates. J Chem Soc Chem Commun 618–619
van Boom JH, Burgers PMJ, Haasnoot CAG (1976) Synthesis of 3′-phosphates of diribonu-cleoside monophosphates via phosphotriester intermediates. Nucleic Acids Res 3:2731–2747
von Boom JH, Haasnoot CAG (1975) Preparation of respectively 5′-phosphoryladenylyl-(3′–5′)-uridine 2′,3′-cyclic phosphate, 3′-phosphate and 2′/3′-phosphates exclusively via phosphotriester intermediates. Nucleic Acids Res. Sp Publ sl 17–120
van Boom JH, de Rooy JFM, Reese CB (1973) The synthesis of oligoribonucleotides. Part X. Preparation of 2′,3′-cyclic phosphates of ribonucleosides and diribonucleoside phosphates via phosphotriester intermediates. J Chem Soc, Perkin Trans 1:2513–2517
Verheyden JPH, Moffatt JG (1970) Halo sugar nucleosides. II. Iodination of secondary hydroxyl groups of nucleosides with methyltriphenoxyphosphonium iodide. J Org Chem 35:2868–2877
Viscontini M, Furuta Y (1973) Über Pterinchemie 43. Synthese von D-Neopterin-3′-phosphat und D-Neopterin-2′,3′-cyclophosphat. Betrachtungen über die Biopterinbiogenese. Helv Chim Acta 56:1819–1825
Walsh DA, Perkins JP, Krebs EG (1968) An adenosine 3′,5′-monophosphate-dependent protein kinase from rabbit skeletal muscle. J Biol Chem 243:3763–3765
Watenpaugh K, Dow J, Jensen LH, Furberg S (1968) Crystal and molecular structure of adenosine 3′,5′-cyclic phosphate. Science 159:206–207
Weber JM, Stewart RB (1975) Cyclic AMP potentiation of interferon antiviral activity and effect of interferon on cellular cyclic AMP levels. J Gen Virology 28:363–372
Wechter WJ (1967) Nucleic acids. I. The synthesis of nucleotides and dinucleoside phosphates containing ara-cytidine. J Med Chem 10:762–773
Wechter WJ (1969) Nucleic acids. VIII. Synthesis and chemistry of ara-cytidine 2′,5′-cyclic phosphate. Phosphate anisotropy. J Org Chem 34:244–247
Weimann G, Haid E, Mühlegger K, Bergmeyer HU, Dietmann K, Michal G, Hochstetter MN (1973) 6-Substituted purineribonucleoside 3′,5′-cyclophosphates. US Patent No 3,712,885
Weiss B (1975) Cyclic nuceotides and disease. University Park Press, Baltimore
Westheimer FH (1957) Studies of the solvolysis of some phosphate esters. Chem Soc (London), Spe Publ 8:1–15
Westheimer FH (1968) Pseudo-rotation in the hydrolysis of phosphate esters. Acc Chem Res 1:70–78
White AA, Aurbach GE, Carlson SJ (1969) Identification of guanyl cyclase in mammalian tissues. Fed Proc 28:473
Wieker H-J, Witzel H (1967) Zum Mechanismus der Ribonuclease-Reaktion 3. Zuordnung der kinetischen Parameter k+1, k−1 k+2 und interpretation von Km. Eur J Biochem 1:251–258
Wierenga W, Woltersom JA (1977) An efficient preparation of cyclic CMP and conversion to its dibutyryl and succinyl derivatives. J Carbohydr Nucleosides Nucleotides 4:189–198
Wilchek M, Salomon Y, Lowe M, Selinger Z (1971) Conversion of protein kinase to a cyclic AMP independent form by affinity chromatography on N6-caproyl 3′,5′-cyclic adenosine monophosphate-sepharose. Biochem Biophys Res Commun 45:1117–1183
Willingham MC, Pastan I (1975) Cyclic AMP modulates microvillus formation and agglutinability in transformed and normal mouse fibroblasts. Proc Natl Acad Sci USA 72:1263–1267
Winkley MW, Robins RK (1968) Pyrimidine nucleoside. I. The synthesis of 6-methylcytidine, 6-methyluridine, and related 6-methylpyrimidine nucleosides. J Org Chem 33:2822–2827
Witkowski JT, Robins RK, Sidwell RW, Simon LN (1972) Design, synthesis, and broad spectrum antiviral activity of 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides. J Med Chem 15:1150–1154
Woenckhaus C, Pfleiderer G (1965) Biochemische Eigenschaften der coenzymanaloga nicotinamid-purin-dinucleotid, nicotinamid-1-desazapurine-dinucleotid und nicotinamid-benzimidazol-dinucleotid. Biochem Z 341:495–501
Woods WD, Waitzman MB (1970) Isolation of cyclic 3′,5′-adenosine monophosphate on a neutral silicic acid-glass microfiber matrix. J Chromatogr 47:536–542
Yagura TS, Sigman CC, Sturm PA, Reist EJ, Johnson HL, Miller JP (1980) Mapping cyclic AMP binding sites on type I and type II cyclic AMP-dependent protein kinases using 2-substituted derivatives of cyclic AMP. Biochem Biophys Res Commun 92:463–469
Yamaji N, Ishiyama J, Kato M, Yoshida F (1977a) 1,N6-Etheno-2-thio-adenosine-3′,5′-cyclic phosphoric acids and their salts. Japan Kokai 77 00,296
Yamaji N, Ishiyama J, Kato M, Yoshida F (1977b) 1,N6-Etheno-2-aminoadenosine 3′,5′-cyclic phosphate. Japan Kokai 77 25,798
Yamaji N, Ishiyama J, Kato M, Yoshida F (1977c) 1,N6-Etheno-2-thioadenosine 3′,5′-cyclic phosphate and its S-alkyl derivatives. Japan Kokai 77 53,897
Yamaji N, Ishiyama J, Kato M, Yoshida F (1977d) 1,N6-Etheno-2-hydroxyadenosine 3′,5′-cyclic phosphate. Japan Kokai 77 77,094
Yamaji N, Ishiyama J, Kato M, Yoshida F (1978) 1,N6-Etheno-2-substituted-adenosine-3′,5′-cyclic phosphoric acids. Japan Kokai 78 12,891
Yamaji N, Kato M (1975) The synthesis of 2-aza-adenosine-3′,5′-cyclic phosphate via 1,N6-etheno-adenosine-3′,5′-cyclic phosphate. Chem Lett 311–314
Yamaji N, Kato M (1978a) 1,N6-Etheno-2-substituted-adenosine-3′,5′-cyclic phosphoric acids. Japan Kokai 78 12,892
Yamaji N, Kato M (1978 b) 2-Substituted adenosine 3′,5′-cyclic phosphoric acids. Japan Kakai 78 46,998
Yamaji N., Katoh M, Ishiyama J, Yoshida F (1976 a) 2-Azapurines. Japan Kokai 76 70,793
Yamaji N, Suda K, Kato M (1976 b) The synthesis of 2-substituted adenosine-3′,5′-cyclic phosphate via 1,N6-etheno-adenosine-3′,5′-cyclic phosphate. Nucleic Acids Res, Sp Publ No. 2, s 59–62
Yamaji N, Suda K, Oneue Y, Kato M (1977 e) Studies on the synthesis of compounds related to adenosine 3′,5′-cyclic phosphate. II. Removal of etheno group of 2-substituted 1,N6-etheno-adenosine 3′,5′-cyclic phosphates. Chem Pharm Bull (Tokyo) 25:3239–3246
Yamaji N, Tahara K, Kato M (1980) Studies on the synthesis of compounds related to adenosine 3′,5′-cyclic phosphate. IV. The synthesis of 2-sulfo-and 2-carboxy-adenosine 3′,5′-cyclic phosphate. Chem Pharm Bull (Tokyo) 28:115–119
Yamaji N, Yuasa Y, Kato M (1976 c) The synthesis of 2-substituted 1,N6-etheno-adenosine-3′,5′-cyclic phosphate by ring reclosure of alkali-hydrolizate of 1,N6-etheno-adenosine-3′,5′-cycric phosphate. Chem Pharm Bull (Tokyo) 24:1561–1567
Yamazaki A, Okutsu M (1978) Cyclization of 5-amino-1-β-D-ribofuranosylimidazole-4-car-boxamide (AICA-riboside): A review. J Heterocycl Chem 15:353–358
Yathindra N, Sundaralingam M (1974) Conformations of cyclic 3′,5′-nucleotides. Effect of the base on the syn-anti conformer distribution. Biochem Biophys Res Commun 56:119–126
Yip KF, Tsou KC (1973) Synthesis of fluorescent adenosine derivatives. Tetrahedron Lett 3087–3090
Yoshikawa M, Kato T, Takenishi T (1967) A novel method for phosphorylation of nucleosides to 5′-nucleotides. Tetrahedron Lett 5065–5068
Yoshikawa M, Kato T, Takenishi T (1969) Studies of phosphorylation. III. Selective phosphorylation of unprotected nucleosides. Bull Chem Soc (Japan) 42:3505–3508
Yung NC, Fox JJ (1961) Nucleosides. X. Anhydronucleosides and related compounds derived from 2′,5′-di-O-trityluridine. J Am Chem Soc 83:3060–3066
Zeilig CE, Goldberg ND (1977) Cell-cycle-related changes of 3′,5′-cyclic GMP levels in novikoff hepatoma cells. Proc Natl Acad Sci USA 74:1052–1956
Zielinski WS, Hynie S, Smrt J (1978) Synthesis of adenosine 3′,5′-cyclic phosphate P-(2-hydroxyethyl)ester and its action as activator of protein kinase. Coll Czech Chem Commun 43:1655–1659
Zielinski WS, Smrt J, Beránek J (1974) Novel preparation of cytidine 5′-phosphate and cytidine 3′,5′-cyclic phosphate. Coll Czech Chem Commun 39:3560–3563
Zimmerman TP (1979) Nucleoside 3′,5′-cyclic monophosphate metabolites of purine analogs. Biochem Pharmacol 28:2533–2539
Zimmerman TP, Rideout JL, Wolberg G, Duncan GS, Elion GB (1976) 2-Fluoroadenosine 3′,5′-monophosphate. J Biol Chem 251:6757–6766
Zmudzka B, Szer W, Shugar D (1962) Preparation and chemical and enzymic properties of phosphate esters of 1-(β-D-glucopyranosyl)-uracil and thymine. Acta Biochim Polonica 9:321–341
Zoller MJ, Kerlavage AR, Taylor SS (1979) Structural comparisons of cAMP-dependent protein kinases I and II from porcine skeletal muscle. J Biol Chem 254:2408–2412
Zoltewicz JA, Clark DF (1972) Kinetics and mechanism of the hydrolysis of guanosine and 7-methylguanosine nucleosides in perchloric acid. J Org Chem 37:1193–1197
Zoltewicz JA, Clark DF, Sharpless TW, Grahe G (1970) Kinetics and mechanism of the acid-catalyzed hydrolysis of some purine nucleosides. J Am Chem Soc 92:1741–1750
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Revankar, G.R., Robins, R.K. (1982). Chemistry of Cyclic Nucleotides and Cyclic Nucleotide Analogs. In: Nathanson, J.A., Kebabian, J.W. (eds) Cyclic Nucleotides. Handbook of Experimental Pharmacology, vol 58 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68111-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-68111-0_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68113-4
Online ISBN: 978-3-642-68111-0
eBook Packages: Springer Book Archive